<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9396869</article-id>
    <article-id pub-id-type="publisher-id">4891</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-022-04891-9</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Using empirical biological knowledge to infer regulatory networks from multi-<italic>omics</italic> data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Pačínková</surname>
          <given-names>Anna</given-names>
        </name>
        <address>
          <email>ana.pacinkova@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Popovici</surname>
          <given-names>Vlad</given-names>
        </name>
        <address>
          <email>vlad.popovici@recetox.muni.cz</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.10267.32</institution-id><institution-id institution-id-type="ISNI">0000 0001 2194 0956</institution-id><institution>RECETOX, Faculty of Science, </institution><institution>Masaryk University, </institution></institution-wrap>Kotlarska 2, Brno, Czech Republic </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.10267.32</institution-id><institution-id institution-id-type="ISNI">0000 0001 2194 0956</institution-id><institution>Faculty of Informatics, </institution><institution>Masaryk University, </institution></institution-wrap>Botanicka 68a, Brno, Czech Republic </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>22</day>
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>22</day>
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>23</volume>
    <elocation-id>351</elocation-id>
    <history>
      <date date-type="received">
        <day>24</day>
        <month>1</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>8</day>
        <month>8</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Integration of multi-<italic>omics</italic> data can provide a more complex view of the biological system consisting of different interconnected molecular components, the crucial aspect for developing novel personalised therapeutic strategies for complex diseases. Various tools have been developed to integrate multi-<italic>omics</italic> data. However, an efficient multi-<italic>omics</italic> framework for regulatory network inference at the genome level that incorporates prior knowledge is still to emerge.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We present IntOMICS, an efficient integrative framework based on Bayesian networks. IntOMICS systematically analyses gene expression, DNA methylation, copy number variation and biological prior knowledge to infer regulatory networks. IntOMICS complements the missing biological prior knowledge by so-called <italic>empirical</italic> biological knowledge, estimated from the available experimental data. Regulatory networks derived from IntOMICS provide deeper insights into the complex flow of genetic information on top of the increasing accuracy trend compared to a published algorithm designed exclusively for gene expression data. The ability to capture relevant crosstalks between multi-<italic>omics</italic> modalities is verified using known associations in microsatellite stable/instable colon cancer samples. Additionally, IntOMICS performance is compared with two algorithms for multi-<italic>omics</italic> regulatory network inference that can also incorporate prior knowledge in the inference framework. IntOMICS is also applied to detect potential predictive biomarkers in microsatellite stable stage III colon cancer samples.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">We provide IntOMICS, a framework for multi-<italic>omics</italic> data integration using a novel approach to biological knowledge discovery. IntOMICS is a powerful resource for exploratory systems biology and can provide valuable insights into the complex mechanisms of biological processes that have a vital role in personalised medicine.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12859-022-04891-9.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Integrative analysis</kwd>
      <kwd>Multimodal omics</kwd>
      <kwd>Bayesian networks</kwd>
      <kwd>Regulatory networks</kwd>
      <kwd>Knowledge discovery</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001824</institution-id>
            <institution>Grantová Agentura České Republiky</institution>
          </institution-wrap>
        </funding-source>
        <award-id>19-08646S</award-id>
        <award-id>19-08646S</award-id>
        <principal-award-recipient>
          <name>
            <surname>Pačínková</surname>
            <given-names>Anna</given-names>
          </name>
          <name>
            <surname>Popovici</surname>
            <given-names>Vlad</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par4">The rapid development of high-throughput technologies has led to large production and availability of <italic>omics</italic> data. Single-<italic>omics</italic> technologies measure simultaneously molecules of the same type from biological samples. On the contrary, multi-<italic>omics</italic> data collect multiple modalities from the same set of samples and describe different aspects of cellular functioning. Therefore, multi-<italic>omics</italic> data contain complementary information and provide a holistic view of the biological system consisting of different interconnected molecular components.</p>
    <p id="Par5">Integration of multi-<italic>omics</italic> data can enhance our understanding of biological systems, crucial for developing novel personalised therapeutic strategies for complex diseases. Hence, developing a computational framework to infer regulatory relationships by integrating multiple modalities is one of the most relevant and challenging problems in systems biology.</p>
    <p id="Par6">The regulatory network inference from high-throughput data is limited by noise or measurement errors. However, it could be significantly improved by incorporating a wealth of biological prior knowledge from the scientific literature [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Gene regulatory networks inferred from single-<italic>omics</italic> data (gene expression) and prior knowledge were frequently used to model gene-gene interactions [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. However, the flow of genetic information in biological systems is very complex, and gene expression is a product of multiple biological processes and control mechanisms, such as copy number variations (CNVs), transcription factors (TFs), non-coding RNAs, DNA methylations, or histone modifications. TFs bind to regulatory elements in the promoter of a given gene and initiate and regulate its transcription [<xref ref-type="bibr" rid="CR6">6</xref>]. Copy number variations such as amplifications/deletions of a DNA segment can affect gene expression through simple gene dosage effects and result in the overexpression/silencing of given genes [<xref ref-type="bibr" rid="CR7">7</xref>]. DNA methylation of the promoter region is known to down-regulate gene expression by preventing the binding of transcription factors [<xref ref-type="bibr" rid="CR8">8</xref>]. However, plenty of studies suggest that DNA methylation and its effect on gene expression needs to be interpreted differently in particular regions of the gene body [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. Regarding all these aspects, it is crucial to progress from single-<italic>omics</italic> data analysis and derive causal relationships between features from multi-<italic>omics</italic> data.</p>
    <p id="Par7">There are several tools estimating the dependence structure among multi-<italic>omics</italic> data [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], estimating a large number of networks for each gene where different modalities are treated as nodes in a graphical model. Although this approach provides valuable insights, they are limited and should be complemented with gene-gene interactions. Several other tools for gene regulatory network inference from multi-<italic>omics</italic> data based on correlation or regression were proposed [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. However, these tools do not integrate biological prior knowledge from the databases, and their main limitation is missing implementation.</p>
    <p id="Par8">[<xref ref-type="bibr" rid="CR17">17</xref>] propose a framework to identify disease-specific pathways by integrating gene expression, mutation information and prior knowledge through a Bayesian network. One of its drawbacks is data discretisation, which implies substantial information loss. RACER [<xref ref-type="bibr" rid="CR18">18</xref>] models the gene expression as response using transcription factor (TF) data, CNV, DNA methylation, and micro RNA (miRNA) expression signals as explanatory variables. RACER applies a two-stage regression framework: first infers the sample-specific regulatory activities by TFs and miRNAs, which are then used as inputs to infer specific TF/miRNA-gene interactions.</p>
    <p id="Par9">During the last year, some up-and-coming tools were published for integrative analysis of multi-<italic>omics</italic> data utilising prior knowledge to infer regulatory networks. COSMOS [<xref ref-type="bibr" rid="CR19">19</xref>] developed a systematic approach to search public databases for plausible causal links between significantly deregulated TFs, kinases/phosphatases and metabolites. The prior knowledge from differential analysis is then used to systematically search causal paths between the deregulated TFs, kinases/phosphatases, and metabolites using a CARNIVAL and its integer linear programming optimisation approach [<xref ref-type="bibr" rid="CR20">20</xref>]. To derive mechanistic hypotheses for experimental observations using COSMOS, we need a case-control study to perform differential analysis, and these data may not always be available. KiMONo [<xref ref-type="bibr" rid="CR21">21</xref>] optimises sparse group LASSO (SGL; LASSO least absolute shrinkage and selection operator) penalisation [<xref ref-type="bibr" rid="CR22">22</xref>] in the multivariate regression to model gene expression of each gene separately. The gene expression represents the criterion variable, and the input matrix is assembled by the features associated with the gene within the prior. SGL penalises within and between predefined groups of features (the authors call it ‘bi-level’ selection), enabling KiMONo to account for different underlying distributions between the features originating from multi-<italic>omics</italic> data. Finally, these fitted models are aggregated in the final heterogeneous multi-<italic>omics</italic> network. CANTARE [<xref ref-type="bibr" rid="CR23">23</xref>] focuses mainly on relationships between omics modalities. CANTARE fits pairwise regression models across all pairs of <italic>omics</italic> data resulting in the network. The relationships from the resulting network are then utilised with other variables to predict the outcome by predictive logistic regression models.</p>
    <p id="Par10">Motivated mainly by [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], we present IntOMICS, a novel Bayesian framework for multi-<italic>omics</italic> data integration using prior knowledge to infer regulatory networks. Even if the intensive research has deposited a wealth of biological prior knowledge into public databases, some regulatory events between genes are still missing. Although databases such as DbVar [<xref ref-type="bibr" rid="CR24">24</xref>] or iMETHYL [<xref ref-type="bibr" rid="CR25">25</xref>] exist, a database with known CNV/METH and gene expression interactions is missing. Therefore, IntOMICS incorporates a novel approach to biological knowledge discovery—estimates the <italic>empirical</italic> biological knowledge to complement the available data from public databases. IntOMICS is designed to capture relevant crosstalks within and between copy number variation, DNA methylation and gene expression. The model parameters tuning guarantees accurate model design and robust results inference.</p>
    <p id="Par11">The performance of proposed algorithm at the multi-<italic>omics</italic> level is compared with RACER and KiMONo, algorithms that can also incorporate prior knowledge in the inference framework.</p>
    <p id="Par12">Werhli and Husmeier [<xref ref-type="bibr" rid="CR4">4</xref>] algorithm (W &amp;H) represents one of the most relevant gene regulatory network reconstruction tools based on Bayesian networks. Therefore, the W &amp;H algorithm is selected for performance comparison with IntOMICS at the gene expression level. Both algorithms resemble the core formulation of prior distribution and integration of biological prior knowledge. On the contrary, they differ in two key aspects: (i) IntOMICS combines prior knowledge with data-derived evidence—the <italic>empirical</italic> biological knowledge (ii) IntOMICS is designed to infer not only dependencies among gene expression but also between gene expression, DNA methylation and copy number variation. W &amp;H algorithm relies on conventional MCMC sampling, which tends to be slow in convergence and mixing and can often be stuck in low-probability regions. The inclusion of adaptive MCMC simulation and Markov blanket resampling (MBR) [<xref ref-type="bibr" rid="CR26">26</xref>] minimise the weaknesses of the W &amp;H algorithm.</p>
    <p id="Par13">IntOMICS can theoretically be extended with any additional modality if the proposed model assumptions are satisfied. We assume that variables come from the multivariate Gaussian distribution, so no discretisation is needed. In addition, only biologically relevant dependencies respecting the central dogma of molecular biology must be considered.</p>
  </sec>
  <sec id="Sec2">
    <title>Bayesian networks</title>
    <p id="Par14">A Bayesian network (BN) is a graphical model representing probabilistic relationships among random variables. BN is defined by the joint probability distribution over the variables specified by (i) a network structure G represented by a directed acyclic graph (DAG) with a set of nodes (indicating a set of random variables) and a set of directed edges (indicating conditional dependence relations among random variables), and (ii) a family of conditional probability distributions with corresponding parameters characterising the dependencies represented by the set of edges.</p>
    <p id="Par15">Due to the Markov condition (each variable is conditionally independent of the set of all its non-descendants given the set of all its parents), the joint probability distribution factorises as follows:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} P(X_1,\ldots ,X_N | G) = \prod \limits _{j=1}^N P(X_j|X_{pa_j(G)}), \end{aligned}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>N</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∏</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2022_4891_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq1"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$X_1,\ldots ,X_N$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>N</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq1.gif"/></alternatives></inline-formula> are random variables, <inline-formula id="IEq2"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$X_{pa_j(G)}$$\end{document}</tex-math><mml:math id="M6"><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq2.gif"/></alternatives></inline-formula> are parents of <inline-formula id="IEq3"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$X_j$$\end{document}</tex-math><mml:math id="M8"><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq3.gif"/></alternatives></inline-formula> implied by the network structure G.</p>
    <p id="Par16">Learning the Bayesian network structure from the data is one of the most challenging tasks. It is guided by a scoring metric <italic>S</italic>, which assess the agreement between a given network structure and the available data <italic>D</italic>. The aim is to identify the highest-scoring network structure.</p>
    <p id="Par17"><inline-formula id="IEq4"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$S$$\end{document}</tex-math><mml:math id="M10"><mml:mi>S</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq4.gif"/></alternatives></inline-formula> is proportional to the posterior probability of the network structure given the data <inline-formula id="IEq5"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D$$\end{document}</tex-math><mml:math id="M12"><mml:mi>D</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq5.gif"/></alternatives></inline-formula> and factorises into a product where each term depends only on a given node and its parents:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} P(G | D) \propto P(D | G) P(G) = \prod \limits _{j=1}^N S(X_j, X_{pa_j} | D ), \end{aligned}$$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>∝</mml:mo><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∏</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2022_4891_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>The choice of scoring metric either requires the data to be discretised (BDe score, [<xref ref-type="bibr" rid="CR27">27</xref>]) or can only capture linear regulatory relationships (BGe score, [<xref ref-type="bibr" rid="CR28">28</xref>]). The BGe score is developed for continuous data sampled from a multivariate normal distribution. Since gene expression, copy number variation, and DNA methylation data are continuous, and we want to avoid data discretisation because of information loss, we consider BGe scoring metric. Furthermore, it has been shown that BGe remains as powerful as BDe, even in the case of slight departures from the linearity assumption [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
  </sec>
  <sec id="Sec3">
    <title>Methods</title>
    <p id="Par18">We present IntOMICS, a powerful Bayesian framework for multi-<italic>omics</italic> data integration to capture dependencies among different molecular features. Figure <xref rid="Fig1" ref-type="fig">1</xref> summarises the key steps of our novel framework.<fig id="Fig1"><label>Fig. 1</label><caption><p>IntOMICS framework. IntOMICS framework takes as input (i) gene expression matrix <italic>GE</italic> with <inline-formula id="IEq6"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$m$$\end{document}</tex-math><mml:math id="M16"><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq6.gif"/></alternatives></inline-formula> samples and <inline-formula id="IEq7"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_1$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq7.gif"/></alternatives></inline-formula> genes, (ii) the associated copy number variation matrix <inline-formula id="IEq8"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$CNV$$\end{document}</tex-math><mml:math id="M20"><mml:mrow><mml:mi mathvariant="italic">CNV</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq8.gif"/></alternatives></inline-formula> (<inline-formula id="IEq9"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$m$$\end{document}</tex-math><mml:math id="M22"><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq9.gif"/></alternatives></inline-formula> x <inline-formula id="IEq10"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_2$$\end{document}</tex-math><mml:math id="M24"><mml:msub><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq10.gif"/></alternatives></inline-formula>), (iii) the associated DNA methylation matrix of beta-values <inline-formula id="IEq11"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$METH$$\end{document}</tex-math><mml:math id="M26"><mml:mrow><mml:mi mathvariant="italic">METH</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq11.gif"/></alternatives></inline-formula> (<inline-formula id="IEq12"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$m$$\end{document}</tex-math><mml:math id="M28"><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq12.gif"/></alternatives></inline-formula> x <inline-formula id="IEq13"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_3$$\end{document}</tex-math><mml:math id="M30"><mml:msub><mml:mi>n</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq13.gif"/></alternatives></inline-formula>) sampled from the same individuals, and (iv) the biological prior knowledge matrix <inline-formula id="IEq14"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B$$\end{document}</tex-math><mml:math id="M32"><mml:mi>B</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq14.gif"/></alternatives></inline-formula> (<inline-formula id="IEq15"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_1$$\end{document}</tex-math><mml:math id="M34"><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq15.gif"/></alternatives></inline-formula> x <inline-formula id="IEq16"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_1$$\end{document}</tex-math><mml:math id="M36"><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq16.gif"/></alternatives></inline-formula>) with information on known interactions among molecular features. An automatically tuned MCMC algorithm [<xref ref-type="bibr" rid="CR30">30</xref>] estimates parameters and <italic>empirical</italic> biological knowledge. Conventional MCMC algorithm with additional Markov blanket resampling step is used to infer resulting regulatory network structure consisting of three types of nodes: GE nodes (highlighted in green) refer to gene expression levels, CNV nodes (highlighted in blue) refer to copy number variations, and METH nodes (highlighted in red) refer to DNA methylation. Edge weight <inline-formula id="IEq17"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$wi$$\end{document}</tex-math><mml:math id="M38"><mml:mrow><mml:mi mathvariant="italic">wi</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq17.gif"/></alternatives></inline-formula> represents the empirical frequency of given edge over samples of network structures</p></caption><graphic xlink:href="12859_2022_4891_Fig1_HTML" id="MO3"/></fig></p>
    <p id="Par19">IntOMICS integrates the biological knowledge from databases and is designed to capture relevant crosstalks within and between gene expression, copy number variation and DNA methylation. The missing biological prior knowledge is complemented by so-called <italic>empirical</italic> biological knowledge, estimated from the available experimental data. The <italic>empirical</italic> biological knowledge reflects hidden patterns in the available datasets derived from past iterations of the Markov chain.</p>
    <p id="Par20">The proposed framework avoids data discretisation, which implies substantial information loss. IntOMICS parameters tuning guarantees accurate model design and robust results inference. The inclusion of adaptive MCMC simulation and Markov blanket resampling (MBR) [<xref ref-type="bibr" rid="CR26">26</xref>] improves convergence and mixing of the Markov chain.</p>
    <sec id="Sec4">
      <title>Biological prior knowledge integration</title>
      <p id="Par21">Biological prior knowledge with information on known interactions among molecular features is integrated into the regulatory network inference employing a prior probability of the network structure G. As in [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], we define the prior distribution over network structures as:<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} P(G|\beta ) = \frac{e^{-\beta E(G)}}{{Z(\beta )}} = \frac{e^{-\beta E(G)}}{\sum \limits _{G \in {\mathcal {G}}} e^{-\beta E(G)}}, \end{aligned}$$\end{document}</tex-math><mml:math id="M40" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mi>β</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>β</mml:mi><mml:mi>E</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:mi>Z</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>β</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>β</mml:mi><mml:mi>E</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:munder><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>G</mml:mi><mml:mo>∈</mml:mo><mml:mi mathvariant="script">G</mml:mi></mml:mrow></mml:munder><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>β</mml:mi><mml:mi>E</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2022_4891_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq18"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal {G}}$$\end{document}</tex-math><mml:math id="M42"><mml:mi mathvariant="script">G</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq18.gif"/></alternatives></inline-formula> indicates a set of all possible network structures, and the parameter <inline-formula id="IEq19"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M44"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq19.gif"/></alternatives></inline-formula> controls the strength of the influence of the biological prior knowledge. The energy function E(G) measures the agreement between the biological prior knowledge and the current network structure:<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} E(G) = \sum \limits _{j=1}^N \varepsilon (X_j, X_{pa_j(G)}), \end{aligned}$$\end{document}</tex-math><mml:math id="M46" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>E</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:mi>ε</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2022_4891_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \varepsilon (X_j, X_{pa_j(G)}) = \sum \limits _{i \in X_{pa_j}} (1-B_{ij}) + \sum \limits _{i \notin X_{pa_j}} B_{ij}, \end{aligned}$$\end{document}</tex-math><mml:math id="M48" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>ε</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munder><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:munder><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>∉</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:munder><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2022_4891_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>where <italic>B</italic> is adjacency matrix with <inline-formula id="IEq20"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B_{ij} \in [0,1]$$\end{document}</tex-math><mml:math id="M50"><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>∈</mml:mo><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq20.gif"/></alternatives></inline-formula>. The matrix <italic>B</italic> represents the biological prior knowledge with information on known interactions among molecular features. If there is the prior knowledge about the direct interaction from node <italic>i</italic> to node <italic>j</italic>, <inline-formula id="IEq21"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B_{ij} = 1$$\end{document}</tex-math><mml:math id="M52"><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq21.gif"/></alternatives></inline-formula>. If there is the prior knowledge about the interaction of a transcription factor <italic>i</italic> and its target <italic>j</italic>, <inline-formula id="IEq22"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B_{ij} = 0.75$$\end{document}</tex-math><mml:math id="M54"><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.75</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq22.gif"/></alternatives></inline-formula>. If there is no knowledge about the direct interaction from node <italic>i</italic> to node <italic>j</italic>, <inline-formula id="IEq23"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B_{ij} = 0.5$$\end{document}</tex-math><mml:math id="M56"><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq23.gif"/></alternatives></inline-formula>. If we have prior knowledge that there is no edge from node <italic>i</italic> to node <italic>j</italic>, <inline-formula id="IEq24"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B_{ij} = 0$$\end{document}</tex-math><mml:math id="M58"><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq24.gif"/></alternatives></inline-formula>.</p>
      <p id="Par22">Then, from (<xref rid="Equ4" ref-type="">4</xref>) we obtain the upper bound of the partition function <inline-formula id="IEq25"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Z(\beta )$$\end{document}</tex-math><mml:math id="M60"><mml:mrow><mml:mi>Z</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>β</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq25.gif"/></alternatives></inline-formula> (see [<xref ref-type="bibr" rid="CR4">4</xref>]):<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} Z(\beta ) = \prod \limits _{j} \sum \limits _{X_{pa_j}} e^{-\beta \varepsilon (X_j, X_{pa_j(G)}) }. \end{aligned}$$\end{document}</tex-math><mml:math id="M62" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>Z</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>β</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munder><mml:mo movablelimits="false">∏</mml:mo><mml:mi>j</mml:mi></mml:munder><mml:munder><mml:mo movablelimits="false">∑</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:msub></mml:munder><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>β</mml:mi><mml:mi>ε</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2022_4891_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula>In the current experiment, curated regulatory relationships of publicly available network database KEGG [<xref ref-type="bibr" rid="CR31">31</xref>] and target gene-transcription factor associations database ENCODE [<xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR34">34</xref>] are used as prior knowledge. Nevertheless, our approach is not limited to KEGG/ENCODE, any other available database can be used.</p>
    </sec>
    <sec id="Sec5">
      <title>MCMC sampling scheme for Bayesian network structure learning</title>
      <p id="Par23">A complete comparison of posterior probabilities is intractable since the search space of all possible network structures grows super-exponentially with the number of random variables. Hence, a Markov Chain Monte Carlo (MCMC) sampling scheme [<xref ref-type="bibr" rid="CR35">35</xref>] is adopted to generate a sample of network structures from the posterior distribution.</p>
      <p id="Par24">First, we sample a network structure <inline-formula id="IEq26"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_c$$\end{document}</tex-math><mml:math id="M64"><mml:msub><mml:mi>G</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq26.gif"/></alternatives></inline-formula> while keeping the <inline-formula id="IEq27"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M66"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq27.gif"/></alternatives></inline-formula> parameter fixed. We need to define the proposal distribution <inline-formula id="IEq28"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Q(G_c|G_s)$$\end{document}</tex-math><mml:math id="M68"><mml:mrow><mml:mi>Q</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq28.gif"/></alternatives></inline-formula> to draw candidate network structures from an intractable posterior distribution. The candidate network structure <inline-formula id="IEq29"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_c$$\end{document}</tex-math><mml:math id="M70"><mml:msub><mml:mi>G</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq29.gif"/></alternatives></inline-formula> is proposed by either adding, deleting or reversing a particular directed edge from the current network structure <inline-formula id="IEq30"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_s$$\end{document}</tex-math><mml:math id="M72"><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq30.gif"/></alternatives></inline-formula>. Besides a conventional single edge proposal move, the Markov blanket resampling step [<xref ref-type="bibr" rid="CR26">26</xref>] is introduced with a fixed probability <inline-formula id="IEq31"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{MBR}~=~1/15$$\end{document}</tex-math><mml:math id="M74"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">MBR</mml:mi></mml:mrow></mml:msub><mml:mspace width="3.33333pt"/><mml:mo>=</mml:mo><mml:mspace width="3.33333pt"/><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:mn>15</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq31.gif"/></alternatives></inline-formula> to achieve faster mixing and convergence (<inline-formula id="IEq32"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{MBR}$$\end{document}</tex-math><mml:math id="M76"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant="italic">MBR</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq32.gif"/></alternatives></inline-formula> suggested by the authors). The acceptance probability <italic>A</italic> indicates how probable the candidate network structure is with respect to the current network structure, according to the posterior distribution. A candidate network structure proposed from the proposal distribution <inline-formula id="IEq33"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Q(G_c|G_s)$$\end{document}</tex-math><mml:math id="M78"><mml:mrow><mml:mi>Q</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq33.gif"/></alternatives></inline-formula> is accepted according to the Metropolis-Hastings rule [<xref ref-type="bibr" rid="CR36">36</xref>] with the acceptance probability given by:<disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} A = \min \left\{ \frac{P(D|G_c)P(G_c|\beta )Q(G_s|G_c)}{P(D|G_s)P(G_s|\beta )Q(G_c|G_s)},1\right\} . \end{aligned}$$\end{document}</tex-math><mml:math id="M80" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>A</mml:mi><mml:mo>=</mml:mo><mml:mo movablelimits="true">min</mml:mo><mml:mfenced close="}" open="{"><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:mi>β</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>Q</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:mi>β</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>Q</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2022_4891_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula>After each iteration except the sampling phase (see “<xref rid="Sec6" ref-type="sec">Technical details</xref>” section), a new parameter <inline-formula id="IEq34"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta _c$$\end{document}</tex-math><mml:math id="M82"><mml:msub><mml:mi>β</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq34.gif"/></alternatives></inline-formula> for fixed network structure <italic>G</italic> is proposed and accepted according to the following acceptance probability:<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} A_\beta = \min \left\{ \frac{P(G|\beta _c)}{P(G|\beta _s)},1\right\} , \end{aligned}$$\end{document}</tex-math><mml:math id="M84" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>β</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo movablelimits="true">min</mml:mo><mml:mfenced close="}" open="{"><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2022_4891_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq35"><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta _s$$\end{document}</tex-math><mml:math id="M86"><mml:msub><mml:mi>β</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq35.gif"/></alternatives></inline-formula> refers to the current parameter value.</p>
    </sec>
    <sec id="Sec6">
      <title>Technical details</title>
      <p id="Par25">The main steps of IntOMICS are summarised in Algorithm 1.</p>
      <p id="Par26">IntOMICS framework takes as input (i) gene expression matrix <italic>GE</italic> (<inline-formula id="IEq36"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$m$$\end{document}</tex-math><mml:math id="M88"><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq36.gif"/></alternatives></inline-formula> x <inline-formula id="IEq37"><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_1$$\end{document}</tex-math><mml:math id="M90"><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq37.gif"/></alternatives></inline-formula>), (ii) the associated copy number variation matrix <inline-formula id="IEq38"><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$CNV$$\end{document}</tex-math><mml:math id="M92"><mml:mrow><mml:mi mathvariant="italic">CNV</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq38.gif"/></alternatives></inline-formula> (<inline-formula id="IEq39"><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$m$$\end{document}</tex-math><mml:math id="M94"><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq39.gif"/></alternatives></inline-formula> x <inline-formula id="IEq40"><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_2$$\end{document}</tex-math><mml:math id="M96"><mml:msub><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq40.gif"/></alternatives></inline-formula>), (iii) the associated DNA methylation matrix of beta-values <inline-formula id="IEq41"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$METH$$\end{document}</tex-math><mml:math id="M98"><mml:mrow><mml:mi mathvariant="italic">METH</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq41.gif"/></alternatives></inline-formula> (<inline-formula id="IEq42"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$m$$\end{document}</tex-math><mml:math id="M100"><mml:mi>m</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq42.gif"/></alternatives></inline-formula> x <inline-formula id="IEq43"><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_3$$\end{document}</tex-math><mml:math id="M102"><mml:msub><mml:mi>n</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq43.gif"/></alternatives></inline-formula>) sampled from the same individuals, and (iv) the biological prior knowledge matrix <inline-formula id="IEq44"><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B$$\end{document}</tex-math><mml:math id="M104"><mml:mi>B</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq44.gif"/></alternatives></inline-formula> (<inline-formula id="IEq45"><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_1$$\end{document}</tex-math><mml:math id="M106"><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq45.gif"/></alternatives></inline-formula> x <inline-formula id="IEq46"><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_1$$\end{document}</tex-math><mml:math id="M108"><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq46.gif"/></alternatives></inline-formula>) with information on known interactions among molecular features.</p>
      <p id="Par27">DNA methylation is an epigenetic mechanism involving the transfer of a methyl group in CG dinucleotides (CpGs). DNA methylation microarrays use beads with long target-specific probes designed to capture individual CpG sites. Because multiple CpG sites are associated with a single gene, we can use linear regression to detect relevant probes that are associated with the gene expression. If not stated otherwise, we considered individual probes with a statistically significant coefficient (<italic>p</italic>-value <inline-formula id="IEq47"><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$&lt; 0.5$$\end{document}</tex-math><mml:math id="M110"><mml:mrow><mml:mo>&lt;</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq47.gif"/></alternatives></inline-formula>) and <inline-formula id="IEq48"><alternatives><tex-math id="M111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$R^2 &gt; 0.3$$\end{document}</tex-math><mml:math id="M112"><mml:mrow><mml:msup><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0.3</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq48.gif"/></alternatives></inline-formula> as possible regulators of given gene expression. The ordered quantile normalisation [<xref ref-type="bibr" rid="CR37">37</xref>] is used to transform DNA methylation beta-values to Gaussian distribution.</p>
      <p id="Par28">Adaptive MCMC algorithms use information from past iterations of the chain to improve computational efficiency. We use an automatically tuned MCMC algorithm [<xref ref-type="bibr" rid="CR30">30</xref>] with default hyper-parameters to estimate parameter <inline-formula id="IEq49"><alternatives><tex-math id="M113">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M114"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq49.gif"/></alternatives></inline-formula> and <italic>empirical</italic> biological knowledge matrix <inline-formula id="IEq50"><alternatives><tex-math id="M115">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal {B}}$$\end{document}</tex-math><mml:math id="M116"><mml:mi mathvariant="script">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq50.gif"/></alternatives></inline-formula> through multiple phases. The automatically tuned MCMC algorithm consists of several distinct phases.</p>
      <p id="Par29">The first adaptive phase is used to roughly tune the parameter <inline-formula id="IEq51"><alternatives><tex-math id="M117">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M118"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq51.gif"/></alternatives></inline-formula>, more precisely the variance of its proposal distribution <inline-formula id="IEq52"><alternatives><tex-math id="M119">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma _s^2$$\end{document}</tex-math><mml:math id="M120"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>s</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq52.gif"/></alternatives></inline-formula>. The proposal distribution is <inline-formula id="IEq53"><alternatives><tex-math id="M121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta _c~\sim ~N(\beta _s,\sigma _s^2)$$\end{document}</tex-math><mml:math id="M122"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mspace width="3.33333pt"/><mml:mo>∼</mml:mo><mml:mspace width="3.33333pt"/><mml:mi>N</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>s</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq53.gif"/></alternatives></inline-formula>, where <inline-formula id="IEq54"><alternatives><tex-math id="M123">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta _s$$\end{document}</tex-math><mml:math id="M124"><mml:msub><mml:mi>β</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq54.gif"/></alternatives></inline-formula> refers to the current parameter value, and <inline-formula id="IEq55"><alternatives><tex-math id="M125">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta _c$$\end{document}</tex-math><mml:math id="M126"><mml:msub><mml:mi>β</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq55.gif"/></alternatives></inline-formula> refers to the candidate parameter value. The initial value of the parameter <inline-formula id="IEq56"><alternatives><tex-math id="M127">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta _s$$\end{document}</tex-math><mml:math id="M128"><mml:msub><mml:mi>β</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq56.gif"/></alternatives></inline-formula> is randomly drawn from <italic>U</italic>[0, 10], and then we require <inline-formula id="IEq57"><alternatives><tex-math id="M129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta &gt;= 0.5$$\end{document}</tex-math><mml:math id="M130"><mml:mrow><mml:mi>β</mml:mi><mml:mo>&gt;</mml:mo><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq57.gif"/></alternatives></inline-formula>. The initial value <inline-formula id="IEq58"><alternatives><tex-math id="M131">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma _s = 5$$\end{document}</tex-math><mml:math id="M132"><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq58.gif"/></alternatives></inline-formula>.</p>
      <p id="Par30">The transient phase is applied to diagnose whether the chain has reached the mode of the target distribution.</p>
      <p id="Par31">The second adaptive phase is used to fine-tune the variance <inline-formula id="IEq59"><alternatives><tex-math id="M133">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma _s^2$$\end{document}</tex-math><mml:math id="M134"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>s</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq59.gif"/></alternatives></inline-formula>, <inline-formula id="IEq60"><alternatives><tex-math id="M135">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M136"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq60.gif"/></alternatives></inline-formula> parameter estimation and compute the <italic>empirical</italic> biological prior matrix <inline-formula id="IEq61"><alternatives><tex-math id="M137">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal {B}}$$\end{document}</tex-math><mml:math id="M138"><mml:mi mathvariant="script">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq61.gif"/></alternatives></inline-formula>. Assuming <inline-formula id="IEq62"><alternatives><tex-math id="M139">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B_{ij} = 0.5$$\end{document}</tex-math><mml:math id="M140"><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq62.gif"/></alternatives></inline-formula>, the prior knowledge about interaction from node <italic>i</italic> to node <italic>j</italic> is updated during the second adaptive phase after every conventional single edge proposal move. The <inline-formula id="IEq63"><alternatives><tex-math id="M141">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal {B}}_{ij}$$\end{document}</tex-math><mml:math id="M142"><mml:msub><mml:mi mathvariant="script">B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq63.gif"/></alternatives></inline-formula> value corresponds to the ratio of acceptance (number of iterations with accepted candidate edge from node <italic>i</italic> to node <italic>j</italic>) and frequency (number of iterations with proposed candidate edge from node <italic>i</italic> to node <italic>j</italic>) (for details, see Table <xref rid="Tab1" ref-type="table">1</xref>). Reversing an edge is equivalent to deleting the edge and adding the edge in the opposite direction.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Empirical biological knowledge estimation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Edge</th><th align="left">Operation</th><th align="left">Frequency</th><th align="left">Candidate</th><th align="left">Acceptance</th></tr></thead><tbody><tr><td align="left" rowspan="2"><inline-formula id="IEq64"><alternatives><tex-math id="M143">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_i$$\end{document}</tex-math><mml:math id="M144"><mml:msub><mml:mi>G</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq64.gif"/></alternatives></inline-formula><inline-formula id="IEq65"><alternatives><tex-math id="M145">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_j$$\end{document}</tex-math><mml:math id="M146"><mml:msub><mml:mi>G</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq65.gif"/></alternatives></inline-formula></td><td align="left" rowspan="2">Add</td><td align="left" rowspan="2"><inline-formula id="IEq66"><alternatives><tex-math id="M147">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f_{ij} = f_{ij} + 1$$\end{document}</tex-math><mml:math id="M148"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq66.gif"/></alternatives></inline-formula></td><td align="left">Accepted</td><td align="left"><inline-formula id="IEq67"><alternatives><tex-math id="M149">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{ij} = a_{ij} + 1$$\end{document}</tex-math><mml:math id="M150"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq67.gif"/></alternatives></inline-formula></td></tr><tr><td align="left">Rejected</td><td align="left"><inline-formula id="IEq68"><alternatives><tex-math id="M151">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{ij} = a_{ij}$$\end{document}</tex-math><mml:math id="M152"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq68.gif"/></alternatives></inline-formula></td></tr><tr><td align="left" rowspan="2"><inline-formula id="IEq69"><alternatives><tex-math id="M153">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_i$$\end{document}</tex-math><mml:math id="M154"><mml:msub><mml:mi>G</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq69.gif"/></alternatives></inline-formula><inline-formula id="IEq70"><alternatives><tex-math id="M155">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_j$$\end{document}</tex-math><mml:math id="M156"><mml:msub><mml:mi>G</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq70.gif"/></alternatives></inline-formula></td><td align="left" rowspan="2">Delete</td><td align="left" rowspan="2"><inline-formula id="IEq71"><alternatives><tex-math id="M157">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f_{ij} = f_{ij} + 1$$\end{document}</tex-math><mml:math id="M158"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq71.gif"/></alternatives></inline-formula></td><td align="left">Accepted</td><td align="left"><inline-formula id="IEq72"><alternatives><tex-math id="M159">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{ij} = a_{ij}$$\end{document}</tex-math><mml:math id="M160"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq72.gif"/></alternatives></inline-formula></td></tr><tr><td align="left">Rejected</td><td align="left"><inline-formula id="IEq73"><alternatives><tex-math id="M161">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{ij} = a_{ij} + 1$$\end{document}</tex-math><mml:math id="M162"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq73.gif"/></alternatives></inline-formula></td></tr><tr><td align="left" rowspan="4"><inline-formula id="IEq74"><alternatives><tex-math id="M163">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_i$$\end{document}</tex-math><mml:math id="M164"><mml:msub><mml:mi>G</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq74.gif"/></alternatives></inline-formula><inline-formula id="IEq75"><alternatives><tex-math id="M165">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_j$$\end{document}</tex-math><mml:math id="M166"><mml:msub><mml:mi>G</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq75.gif"/></alternatives></inline-formula></td><td align="left" rowspan="4">Reverse</td><td align="left" rowspan="2"><inline-formula id="IEq76"><alternatives><tex-math id="M167">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f_{ij} = f_{ij} + 1$$\end{document}</tex-math><mml:math id="M168"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq76.gif"/></alternatives></inline-formula></td><td align="left" rowspan="2">Accepted</td><td align="left"><inline-formula id="IEq77"><alternatives><tex-math id="M169">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{ij} = a_{ij}$$\end{document}</tex-math><mml:math id="M170"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq77.gif"/></alternatives></inline-formula></td></tr><tr><td align="left"><inline-formula id="IEq78"><alternatives><tex-math id="M171">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{ji} = a_{ji} + 1$$\end{document}</tex-math><mml:math id="M172"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ji</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ji</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq78.gif"/></alternatives></inline-formula></td></tr><tr><td align="left" rowspan="2"><inline-formula id="IEq79"><alternatives><tex-math id="M173">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f_{ji} = f_{ji} + 1$$\end{document}</tex-math><mml:math id="M174"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi mathvariant="italic">ji</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi mathvariant="italic">ji</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq79.gif"/></alternatives></inline-formula></td><td align="left" rowspan="2">Rejected</td><td align="left"><inline-formula id="IEq80"><alternatives><tex-math id="M175">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{ij} = a_{ij} + 1$$\end{document}</tex-math><mml:math id="M176"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq80.gif"/></alternatives></inline-formula></td></tr><tr><td align="left"><inline-formula id="IEq81"><alternatives><tex-math id="M177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{ji} = a_{ji}$$\end{document}</tex-math><mml:math id="M178"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ji</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ji</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq81.gif"/></alternatives></inline-formula></td></tr></tbody></table><table-wrap-foot><p>Assuming there is no prior knowledge about the direct interaction from node <italic>i</italic> to node <italic>j</italic>, the <italic>empirical</italic> biological matrix <inline-formula id="IEq82"><alternatives><tex-math id="M179">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal {B}}$$\end{document}</tex-math><mml:math id="M180"><mml:mi mathvariant="script">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq82.gif"/></alternatives></inline-formula> is estimated, with <inline-formula id="IEq83"><alternatives><tex-math id="M181">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal {B}}_{ij} = \frac{a_{ij}}{f_{ij}} \in [0,1]$$\end{document}</tex-math><mml:math id="M182"><mml:mrow><mml:msub><mml:mi mathvariant="script">B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mo>∈</mml:mo><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq83.gif"/></alternatives></inline-formula></p></table-wrap-foot></table-wrap></p>
      <p id="Par32">The <italic>empirical</italic> biological matrix <inline-formula id="IEq84"><alternatives><tex-math id="M183">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal {B}}$$\end{document}</tex-math><mml:math id="M184"><mml:mi mathvariant="script">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq84.gif"/></alternatives></inline-formula> and the parameter <inline-formula id="IEq85"><alternatives><tex-math id="M185">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M186"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq85.gif"/></alternatives></inline-formula> determined by the second adaptive phase are used in the last sampling phase. In this phase, IntOMICS applies a <italic>greedy horizon</italic> approach. Three independent paths are executed with a fixed BGe score (except the MBR step). The most probable path is chosen after every 500 iterations. In our simulation, two independent samples of network structures are produced. Each sample consists of 200,000 DAGs (with a burn-in period of 100,000 iterations). The resulting samples of DAGs are thinned—discarded all but every 500th DAG. The burn-in period of 100,000 iterations and thinning frequency of 500 are arbitrary choices. We tested different settings of these parameters using in silico dataset with known network structure but they did not influence the resulting accuracy (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figs. S1 and S2).</p>
      <p id="Par33">Distinct DAGs can describe the same set of independence relations and have the same likelihood score. Such DAGs are from the same equivalence class. The equivalence class can be represented by completed partially directed acyclic graphs (CPDAGs). Therefore, we convert DAGs into corresponding CPDAGs and discard duplicated CPDAGs.</p>
      <p id="Par34">The convergence of resulting Markov chains is examined using the <inline-formula id="IEq86"><alternatives><tex-math id="M187">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$c_{\mathop {rms}}$$\end{document}</tex-math><mml:math id="M188"><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi mathvariant="italic">rms</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq86.gif"/></alternatives></inline-formula> measure [<xref ref-type="bibr" rid="CR38">38</xref>]. The <inline-formula id="IEq87"><alternatives><tex-math id="M189">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$c_{\mathop {rms}}$$\end{document}</tex-math><mml:math id="M190"><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi mathvariant="italic">rms</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq87.gif"/></alternatives></inline-formula> threshold is given by the third quartile of <inline-formula id="IEq88"><alternatives><tex-math id="M191">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$|c_{\mathop {rms_k}} - c_{\mathop {rms_{k-1}}}|$$\end{document}</tex-math><mml:math id="M192"><mml:mrow><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>r</mml:mi><mml:mi>m</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>r</mml:mi><mml:mi>m</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq88.gif"/></alternatives></inline-formula> for each iteration <italic>k</italic>. If the <inline-formula id="IEq89"><alternatives><tex-math id="M193">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$c_{\mathop {rms}}$$\end{document}</tex-math><mml:math id="M194"><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi mathvariant="italic">rms</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq89.gif"/></alternatives></inline-formula> value of the last 100 iterations (after thinning) is smaller than the <inline-formula id="IEq90"><alternatives><tex-math id="M195">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$c_{\mathop {rms}}$$\end{document}</tex-math><mml:math id="M196"><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi mathvariant="italic">rms</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq90.gif"/></alternatives></inline-formula> threshold, the MCMC simulation stops. Otherwise, the simulation proceeds until this condition is met. Subsequently, we discard the CPDAGs from the burn-in period.</p>
      <p id="Par35">The strength of the probabilistic relationships expressed by the edges in the resulting network structure is measured as their empirical frequency over both independent sets of CPDAGs.</p>
      <p id="Par36">In the context of gene expression, gene transcription is usually controlled by a small number of transcription factors. In contrast, a transcription factor can control an almost unlimited number of genes. Therefore, we apply the upper bound of the number of parents for each GE node: each GE node can have at most three GE parent nodes and one corresponding CNV node. There is no restriction on the number of METH parents for given GE node. CNV and METH nodes cannot have any parents. This restriction is supported by the biological literature [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
      <p id="Par37">Analyses were carried out using the free R software (www.r-project.org) version 4.0.0.<graphic position="anchor" xlink:href="12859_2022_4891_Figa_HTML" id="MO10"/></p>
    </sec>
  </sec>
  <sec id="Sec7">
    <title>Data and test procedures</title>
    <p id="Par38">Objective assessment of regulatory network inference is challenging [<xref ref-type="bibr" rid="CR40">40</xref>], especially if we are interested in multiple molecular features, such as gene expression, copy number variation, and DNA methylation.</p>
    <p id="Par39">DREAM (the Dialogue on Reverse Engineering Assessment and Methods) project [<xref ref-type="bibr" rid="CR40">40</xref>] was established to objective assess network inference methods on benchmark data sets. We use one of the DREAM4 gene expression datasets [<xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR43">43</xref>] for the IntOMICS evaluation at gene expression level. But we must keep in mind, that simulated datasets cannot fully reflect underlying biological processes.</p>
    <p id="Par40">We use also several real datasets to evaluate the IntOMICS performance considering multi-<italic>omics</italic> data. There are multiple publicly available databases with well-known interaction pathways. We can use them as the ground truth. Nevertheless, a certain level of disagreement is likely to emerge due to biological diversity. Well-known interaction pathways capture only simplified representations of mechanisms ongoing in most populations under given conditions. As a test case for IntOMICS, we focus mainly on the Wnt/Wingless and MAPK signalling pathways that have a prominent role in cancer development. Hence, they have been extensively studied in the context of colon cancer, and most of the key gene-gene interactions have been revealed and experimentally tested [<xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR47">47</xref>]. Besides wild-type/normal tissue experiments, we assess the IntOMICS performance in samples affected by some perturbation (interventional gene expression data from knock-out experiments, tumour tissues).</p>
    <p id="Par41">DNA methylation is one of the most intensely studied epigenetic modifications of DNA that is important for the normal regulation of transcription, embryonic development, genomic imprinting, genome stability and chromatin structure [<xref ref-type="bibr" rid="CR48">48</xref>]. The Beta-value (frequently converted to M-value through a logistic transformation) is a metric to measure DNA methylation levels. The Beta-value ranges between 0 (completely unmethylated) and 1 (every copy of the site was methylated) and follows the Beta distribution [<xref ref-type="bibr" rid="CR49">49</xref>]. The copy number variations contain information on gains and losses of genetic information. CNV data are represented by continuous segment mean values reflecting the log2 ratio of probe intensities. Diploid regions have a segment mean of zero, amplified regions have positive values, and deletions have negative values [<xref ref-type="bibr" rid="CR50">50</xref>].</p>
    <sec id="Sec8">
      <title>Datasets</title>
      <p id="Par42">A summary of all data sets used in this study can be found in Table <xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of all used data sets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Dataset</th><th align="left">Investigated gene set</th><th align="left">Samples</th><th align="left">Details</th></tr></thead><tbody><tr><td align="left">GSE127960 ZIC5 WT</td><td align="left">16GE / 0CNV / 0METH</td><td char="." align="char">2</td><td align="left">HCT116 colon cancer cell line</td></tr><tr><td align="left" rowspan="2">GSE127960 ZIC5 KO</td><td align="left" rowspan="2">16GE / 0CNV / 0METH</td><td char="." align="char" rowspan="2">4</td><td align="left">HCT116 colon cancer cell line</td></tr><tr><td align="left">ZIC5 knockout</td></tr><tr><td align="left" rowspan="2">TCGA-COAD MSS</td><td align="left" rowspan="2">24GE / 24CNV / 4METH</td><td char="." align="char" rowspan="2">27</td><td align="left">Primary tumour stage II/III</td></tr><tr><td align="left">With MSS phenotype</td></tr><tr><td align="left" rowspan="2">TCGA-COAD MSI</td><td align="left" rowspan="2">24GE / 24CNV / 3METH</td><td char="." align="char" rowspan="2">69</td><td align="left">Primary tumour</td></tr><tr><td align="left">With MSI phenotype</td></tr><tr><td align="left" rowspan="2">TCGA-COAD NAT</td><td align="left" rowspan="2">24GE / 24CNV / 16METH</td><td char="." align="char" rowspan="2">19</td><td align="left">Histologically normal tissue</td></tr><tr><td align="left">Adjacent to the tumour</td></tr><tr><td align="left" rowspan="2">DREAM4 1-5</td><td align="left" rowspan="2">10GE / 0CNV / 0METH</td><td char="." align="char" rowspan="2">1</td><td align="left">Five independent in silico networks</td></tr><tr><td align="left">To assess the consistency of prediction</td></tr><tr><td align="left">TCGA-AML</td><td align="left">25GE / 25CNV / 25METH</td><td char="." align="char">173</td><td align="left">Acute myeloid leukemia</td></tr><tr><td align="left" rowspan="2">PETACC-3 MSS</td><td align="left" rowspan="2">39GE / 23CNV / 0METH</td><td char="." align="char" rowspan="2">176</td><td align="left">Primary tumour stage III</td></tr><tr><td align="left">With MSS phenotype</td></tr></tbody></table><table-wrap-foot><p><italic>MSS</italic> microsatellite stability, <italic>MSI</italic> microsatellite instability, <italic>NAT</italic> histologically normal tissue adjacent to the tumour, <italic>GE</italic> gene expression, <italic>CNV</italic> copy number variation, <italic>METH</italic> methylation probe, <italic>KO</italic> knockout, <italic>WT</italic> wild-type, <italic>AML</italic> acute myeloid leukemia</p></table-wrap-foot></table-wrap></p>
      <p id="Par43">The Cancer Genome Atlas (TCGA) [<xref ref-type="bibr" rid="CR51">51</xref>] provides publicly available multi-<italic>omics</italic> datasets for human cancers, including colon cancer (COAD) and its histologically normal tissue adjacent to the tumour (NAT). The copy number variation of the associated genes from TCGA-COAD samples were downloaded from the Broad Institute GDAC Firehose (<ext-link ext-link-type="uri" xlink:href="https://gdac.broadinstitute.org/">https://gdac.broadinstitute.org/</ext-link>; accessed 30 December 2020). We use only samples with DNA methylation data from Illumina Infinium HumanMethylation450 (450K) BeadChip array available. The resulting subset of the TCGA-COAD consists of n = 115 samples (27 microsatellite stable phenotype (MSS) stage II/III, 69 microsatellite instable phenotype (MSI), 19 NAT). Several TCGA-COAD samples lack information on microsatellite status. These samples were classified into MSI/MSS groups using MSI gene expression signature [<xref ref-type="bibr" rid="CR52">52</xref>].</p>
      <p id="Par44">GSE127960 includes the gene expression profiling of the human colon cancer cell lines HCT116 with ZIC5 wild-type (ZIC5 WT) and ZIC5 knockout (ZIC5 KO) replicates.</p>
      <p id="Par45">DREAM4 dataset [<xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR43">43</xref>] consists of five in silico networks with 10 nodes. We use steady state data reflecting gene expression measurements.</p>
      <p id="Par46">We utilise another dataset originating from TCGA [<xref ref-type="bibr" rid="CR51">51</xref>]. We downloaded the processed TCGA-AML (acute myeloid leukemia) dataset used in the original RACER publication [<xref ref-type="bibr" rid="CR18">18</xref>] to reproduce the most relevant results. TCGA-AML dataset consists of gene expression, copy number variation, DNA methylation and miRNA expression data. Methylation data are represented by the mean of multiple probes corresponding to a given gene.</p>
      <p id="Par47">PETACC-3 clinical trial [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] investigates the benefit of irinotecan in the adjuvant treatment of stage III colon cancer patients. We use gene expression and copy number variation data of 176 MSS stage III colon cancer samples (PETACC-3 MSS). Missing MSS/MSI phenotype was determined by the MSI gene expression signature mentioned above.</p>
    </sec>
    <sec id="Sec9">
      <title>Evaluation criteria</title>
      <p id="Par48">One of the main performance indexes is used the receiver-operating characteristic curve (ROC) as a function of the edge weights and area under the receiver-operating characteristic curve (AUC). Edge weight in the resulting network structure reflects its empirical frequency over the final set of CPDAGs.</p>
      <p id="Par49">From a practical point of view, the edge weight expresses confidence in the real edge presence. If not stated otherwise, we define a threshold for a presence of an edge as 0.75 quantile of all present edges in a given network structure.</p>
      <p id="Par50">The IntOMICS performance at gene expression level is compared with the W &amp;H algorithm—one of the most relevant gene regulatory network reconstruction tools based on Bayesian networks [<xref ref-type="bibr" rid="CR4">4</xref>]. The W &amp;H algorithm was designed to infer only dependencies among gene expression data. Thus, we exclude CNV-GE and METH-GE edges identified by IntOMICS in the performance comparison of these two algorithms. The criterion of the 83% confidence intervals (CIs) overlap [<xref ref-type="bibr" rid="CR55">55</xref>] is used to test if there is a difference in the performance of both algorithms. To measure the agreement between IntOMICS and W &amp;H algorithm, we add another performance metric—Cohen’s <inline-formula id="IEq91"><alternatives><tex-math id="M197">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\kappa$$\end{document}</tex-math><mml:math id="M198"><mml:mi>κ</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq91.gif"/></alternatives></inline-formula> coefficient. To assess which of the tested algorithms estimate more biologically relevant gene-gene interactions, we define a set of edges (missing in the prior knowledge) identified exclusively by IntOMICS or W &amp;H, respectively, and compare them against other publicly available interaction databases [<xref ref-type="bibr" rid="CR56">56</xref>–<xref ref-type="bibr" rid="CR58">58</xref>].</p>
      <p id="Par51">To evaluate the IntOMICS performance in real datasets, we select the Wnt signalling pathway from the KEGG database and consider only interactions experimentally validated by low-throughput experiments listed in the BioGrid database [<xref ref-type="bibr" rid="CR57">57</xref>]. We refer to this pathway as the <italic>gold standard</italic> Wnt pathway (GS Wnt pathway). GS Wnt pathway includes only interactions with strong experimental support but includes many false negatives. The missing interactions in the GS Wnt pathway are not necessarily incorrect. Regulatory networks derived using TCGA-COAD MSI/NAT, and GSE127960 ZIC5 WT/KO are compared with the GS Wnt pathway used as the ground truth.</p>
      <p id="Par52"><inline-formula id="IEq92"><alternatives><tex-math id="M199">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M200"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq92.gif"/></alternatives></inline-formula>-<italic>catenin regulation in MSI colon cancer</italic> Activating mutations in <inline-formula id="IEq93"><alternatives><tex-math id="M201">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M202"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq93.gif"/></alternatives></inline-formula>-catenin (CTNNB1) result in decreased phosphorylation by GSK3<inline-formula id="IEq94"><alternatives><tex-math id="M203">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M204"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq94.gif"/></alternatives></inline-formula> and increased Wnt signalling through the Tcf/Lef transcription factors. These mutations are more frequent in microsatellite instable (MSI) colon cancer [<xref ref-type="bibr" rid="CR59">59</xref>–<xref ref-type="bibr" rid="CR61">61</xref>]. KEGG Colorectal cancer pathway has MSI specific information on missing interaction between GSK3<inline-formula id="IEq95"><alternatives><tex-math id="M205">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M206"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq95.gif"/></alternatives></inline-formula> and CTNNB1 genes. Therefore, we compare regulatory networks inferred by IntOMICS using both TCGA-COAD MSI samples and TCGA-COAD NAT samples. We choose 24 genes from the KEGG Wnt signalling pathway.</p>
      <p id="Par53"><italic>SLC2A1 regulation in colon cancer cell lines</italic> [<xref ref-type="bibr" rid="CR62">62</xref>] found that the effectors of Wnt signalling <inline-formula id="IEq96"><alternatives><tex-math id="M207">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M208"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq96.gif"/></alternatives></inline-formula>-catenin (CTNNB1) and TCF7L2 in collaboration with ZIC proteins directly regulate SLC2A1 gene expression. We choose gene expression of 14 genes from the KEGG Wnt signalling pathway together with ZIC5 and SLC2A1 genes and observe any difference in SLC2A1 regulation between ZIC5 WT and ZIC5 KO samples. GSE127960 data set is used to assess the IntOMICS performance only at the gene expression level.</p>
      <p id="Par54"><italic>CNVs specific for MSS colon cancer</italic> The TCGA colon cancer (TCGA-COAD) microsatellite stable (MSS) samples were used to evaluate IntOMICS ability to infer dependencies among different molecular features—gene expression and copy number variation. In this part, we utilise gene expression, DNA methylation, and CNV data of TCGA-COAD MSS stage II/III samples (n = 27). We choose a subset of 24 genes from the KEGG Colorectal cancer pathway concerning CNVs identified by [<xref ref-type="bibr" rid="CR54">54</xref>] in MSS stage II/III primary tumours. [<xref ref-type="bibr" rid="CR54">54</xref>] identified several MSS specific aberrations. We focus on amplification of KRAS, MYC, BIRC5, CCND1, RAC3 and deletion of SMAD4.</p>
      <p id="Par55"><italic>DNA methylation specific for MSI colon cancer</italic> The TCGA colon cancer (TCGA-COAD) microsatellite instable (MSI) samples have characteristic molecular biomarkers such as gene expression silencing through the MLH1 promoter hypermethylation [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. TCGA-COAD MSI samples were used to evaluate IntOMICS ability to infer dependencies among other molecular features—gene expression and DNA methylation. In this part, we utilise gene expression, DNA methylation, and CNV data of TCGA-COAD MSI samples (n = 69). We choose a subset of 24 genes from the KEGG Colorectal cancer pathway and MLH1. Because there are many methylation probes with significant regression coefficient and <inline-formula id="IEq97"><alternatives><tex-math id="M209">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$R^2 &gt; 0.3$$\end{document}</tex-math><mml:math id="M210"><mml:mrow><mml:msup><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0.3</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq97.gif"/></alternatives></inline-formula>, we perform differential methylation analysis using ChAMP R-package [<xref ref-type="bibr" rid="CR65">65</xref>]. We select CpG island methylation probes from the promoter region with differential methylation between NAT and MSI samples (<italic>p</italic>-value <inline-formula id="IEq98"><alternatives><tex-math id="M211">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$&lt; 0.05$$\end{document}</tex-math><mml:math id="M212"><mml:mrow><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq98.gif"/></alternatives></inline-formula>), and the absolute value of delta beta was greater than its 0.75 quantile.</p>
      <p id="Par56"><italic>In Silico Dataset</italic> We use in silico dataset DREAM4 with the gold standard network structure available to evaluate the IntOMICS performance at the gene expression level. For each network, 50 % of the known interactions were randomly selected as the prior knowledge.</p>
      <p id="Par57"><italic>Comparison with Algorithms for Multi</italic>-<italic>Omics</italic><italic>Regulatory Network Inference</italic> Finally, we compare IntOMICS to two existing approaches focused on modelling interactions between multi-<italic>omics</italic> modalities with available implementation, namely RACER [<xref ref-type="bibr" rid="CR18">18</xref>] and KiMONo [<xref ref-type="bibr" rid="CR21">21</xref>]. Both methods can predict the interaction between CNV/METH/miRNA and GE modalities. miRNA-GE interactions are excluded from this comparison. RACER can also predict GE-GE interactions restricted to TFs and their targets. KiMONo is designed to evaluate only GE-GE interactions listed in the prior knowledge. For this comparison, we use TCGA-AML (acute myeloid leukemia) dataset from the RACER publication [<xref ref-type="bibr" rid="CR18">18</xref>] to reproduce the most relevant results. In this part, we focus on 25 genes from the Notch signalling pathway, that is crucial in malignant transformation and therefore extensively studied [<xref ref-type="bibr" rid="CR66">66</xref>]. Two out of these 25 genes are known TFs with targets from Notch signalling pathway.</p>
    </sec>
    <sec id="Sec10">
      <title>Real application of InfOMICS: ABCG2-related chemoresistance in MSS stage III colon cancer</title>
      <p id="Par58">Resistance to chemotherapy is a major clinical problem in colon cancer treatment. Mechanisms associated with chemoresistance and novel biomarkers can identify patients with benefit from irinotecan-based regimens that could substantially improve the selection of cancer therapy for the individual patient.</p>
      <p id="Par59">PETACC-3 clinical trial [<xref ref-type="bibr" rid="CR53">53</xref>] randomised colon cancer patients to fluorouracil/leucovorin (5FU/FA) <inline-formula id="IEq99"><alternatives><tex-math id="M213">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$+/-$$\end{document}</tex-math><mml:math id="M214"><mml:mrow><mml:mo>+</mml:mo><mml:mo stretchy="false">/</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq99.gif"/></alternatives></inline-formula> irinotecan treatment groups. The combination of ABCG2 and TOP1 gene expression significantly divided the stage III colon cancer patients enrolled in PETACC-3 into two groups regarding benefit from adjuvant treatment with FOLFIRI [<xref ref-type="bibr" rid="CR67">67</xref>].</p>
      <p id="Par60">ABCG2 plays an essential role as an efflux transporter with various substrates, including chemotherapy drugs. Thus it is responsible for chemotherapy failure [<xref ref-type="bibr" rid="CR68">68</xref>]. MYCN (by analogy, c-MYC) can contribute to irinotecan chemoresistance by regulating a specific set of ABC transporter genes, including ABCG2. Direct interaction was determined by chromatin immunoprecipitation (ChIP) assays and luciferase-reporter assays [<xref ref-type="bibr" rid="CR69">69</xref>]. The authors have shown that ABCG2 gene expression is positively regulated by MYCN in neuroblastoma cell lines.</p>
      <p id="Par61">The gene expression of ABCG2 could be increased by activation of mitogen-activated protein kinase cascade via phosphorylation of extracellular regulated kinase ERK1/2 and c-jun NH-terminal kinase/stress-activated protein kinase (JNK/SAPK) [<xref ref-type="bibr" rid="CR70">70</xref>].</p>
      <p id="Par62">We use IntOMICS to investigate mechanisms associated with chemoresistance using 176 MSS stage III colon cancer samples from the PETACC-3 (PETACC-3 MSS) clinical trial [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. We select 37 genes from the KEGG MAPK signalling pathway together with MYCN and ABCG2 genes. Copy number variation data are available for 23 out of 39 selected genes. Both PETACC-3 MSS samples treated by 5FU/FA (PETACC-3 MSS 5FU/FA) and PETACC-3 MSS samples treated by 5FU/FA + irinotecan (PETACC-3 MSS FOLFIRI) are dichotomized by 5-year relapse-free survival (RFS) into high/low-RFS groups (Table <xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Number of samples in PETACC-3 clinical trial according to the treatment and relapse-free survival</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">5FU/FA</th><th align="left">FOLFIRI</th></tr></thead><tbody><tr><td align="left">Low-RFS</td><td char="." align="char">31</td><td char="." align="char">34</td></tr><tr><td align="left">High-RFS</td><td char="." align="char">53</td><td char="." align="char">58</td></tr></tbody></table><table-wrap-foot><p><italic>5FU/FA</italic> fluorouracil/leucovorin, <italic>FOLFIRI</italic> fluorouracil/leucovorin with irinotecan, <italic>RFS</italic> relapse-free survival</p></table-wrap-foot></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec11">
    <title>Results</title>
    <p id="Par63">The performance of IntOMICS and W &amp;H algorithm in TCGA-COAD and GSE127960 datasets is shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>. Corresponding AUC with 83% CIs, Cohen’s <inline-formula id="IEq100"><alternatives><tex-math id="M215">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\kappa$$\end{document}</tex-math><mml:math id="M216"><mml:mi>κ</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq100.gif"/></alternatives></inline-formula> coefficient, and running time can be found in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1. In TCGA-COAD NAT and TCGA-COAD MSI datasets, the IntOMICS performance is significantly higher than the W &amp;H. There is no statistically significant difference in the performance in GSE127960 ZI5 WT and GSE127960 ZI5 KO datasets.<fig id="Fig2"><label>Fig. 2</label><caption><p>Performance comparison of IntOMICS and W &amp;H algorithm [<xref ref-type="bibr" rid="CR4">4</xref>] using real datasets. Receiver-operating characteristic curve (as a function of the edge weights) serves as the main performance index. Gold standard Wnt signalling pathway is used as the ground truth. NAT histologically normal tissue adjacent to the tumour; MSI microsatellite instability; WT wild-type; KO knockout</p></caption><graphic xlink:href="12859_2022_4891_Fig2_HTML" id="MO11"/></fig></p>
    <p id="Par64">Cohen’s <inline-formula id="IEq101"><alternatives><tex-math id="M217">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\kappa$$\end{document}</tex-math><mml:math id="M218"><mml:mi>κ</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq101.gif"/></alternatives></inline-formula> ranges between 0.12 to 0.38. In the TCGA-COAD datasets, Cohen’s <inline-formula id="IEq102"><alternatives><tex-math id="M219">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\kappa$$\end{document}</tex-math><mml:math id="M220"><mml:mi>κ</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq102.gif"/></alternatives></inline-formula> is very low, which reflects the statistically significant difference in the performance. In the GSE127960 ZIC5 WT dataset, Cohen’s <inline-formula id="IEq103"><alternatives><tex-math id="M221">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\kappa = 0.19$$\end{document}</tex-math><mml:math id="M222"><mml:mrow><mml:mi>κ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.19</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq103.gif"/></alternatives></inline-formula> is also low, even if the performance of both algorithms is similar. However, we can notice the lack of convergence in W &amp;H MCMC simulation. As a result of the Markov chain poor convergence, we can detect apparent anomalies in the trace plots of <inline-formula id="IEq104"><alternatives><tex-math id="M223">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M224"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq104.gif"/></alternatives></inline-formula> values (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3a, b) and inconsistency of posterior probabilities of the edges (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4a, b). [<xref ref-type="bibr" rid="CR4">4</xref>] decided to run a fixed number of MCMC simulations for performance evaluation. We followed the same procedure in the W &amp;H application and found out that this setting is insufficient in some datasets. Consequently, using a measure of convergence, such as the <inline-formula id="IEq105"><alternatives><tex-math id="M225">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$c_{\mathop {rms}}$$\end{document}</tex-math><mml:math id="M226"><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi mathvariant="italic">rms</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq105.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR38">38</xref>], is necessary for every MCMC simulation. IntOMICS trace plots of <inline-formula id="IEq106"><alternatives><tex-math id="M227">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M228"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq106.gif"/></alternatives></inline-formula> values and the edge posterior probabilities of two independent MCMC simulations can be found in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figs. S5 and S6.</p>
    <p id="Par65"><inline-formula id="IEq107"><alternatives><tex-math id="M229">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M230"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq107.gif"/></alternatives></inline-formula>-<italic>catenin regulation in MSI colon cancer</italic> The W &amp;H algorithm identified the interaction from CTNNB1 to GSK3<inline-formula id="IEq108"><alternatives><tex-math id="M231">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M232"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq108.gif"/></alternatives></inline-formula> in both TCGA-COAD NAT and TCGA-COAD MSI datasets. Using the predefined threshold of edge weights, the interaction from GSK3<inline-formula id="IEq109"><alternatives><tex-math id="M233">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M234"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq109.gif"/></alternatives></inline-formula> to CTNNB1 was missing in the resulting regulatory network derived by IntOMICS in TCGA-COAD NAT samples. The interaction was present in 50% of CPDAGs. In TCGA-COAD MSI samples, IntOMICS did not identify the interaction between these genes at all, even if <inline-formula id="IEq110"><alternatives><tex-math id="M235">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B_{ij} = 1$$\end{document}</tex-math><mml:math id="M236"><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq110.gif"/></alternatives></inline-formula> for i = GSK3<inline-formula id="IEq111"><alternatives><tex-math id="M237">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M238"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq111.gif"/></alternatives></inline-formula> and j = CTNNB1. This result suggests IntOMICS can discover relevant data-derived interactions despite distinct prior knowledge. We can conclude the edge weight needs to be considered carefully when interpreting the results and drawing conclusions.</p>
    <p id="Par66">In the TCGA-COAD NAT dataset, 17% and 13% of edges identified exclusively by the W &amp;H and IntOMICS algorithm were found in other databases, respectively.</p>
    <p id="Par67"><italic>SLC2A1 regulation in colon cancer cell lines</italic> Based on the [<xref ref-type="bibr" rid="CR62">62</xref>] experiment, we assume SLC2A1 is directly regulated by ZIC5, CTNNB1, and TCF7L2 in ZIC5 WT samples (<inline-formula id="IEq112"><alternatives><tex-math id="M239">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$B_{ij} = 1$$\end{document}</tex-math><mml:math id="M240"><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq112.gif"/></alternatives></inline-formula>).</p>
    <p id="Par68">In ZIC5 WT samples, both W &amp;H and IntOMICS revealed all three interactions. Moreover, IntOMICS revealed GSK3B as the direct regulator of SLC2A1 and TCF7L2 as the direct regulator of ZIC5. W &amp;H revealed CTNNB1 as the direct regulator of ZIC5.</p>
    <p id="Par69">We expect a difference in SLC2A1 and ZIC5 regulation in ZIC5 KO samples. In ZIC5 KO samples, W &amp;H revealed the same set of SLC2A1 regulators. The difference is missing interaction between CTNNB1 and ZIC5. IntOMICS identified a direct regulation from CTNNB1, TCF7L2, and CHD8 to SLC2A1. IntOMICS identified the same interaction from TCF7L2 to ZIC5 as in WT samples.</p>
    <p id="Par70">In the GSE127960 WT dataset, 7% and 18% of edges identified exclusively by the W &amp;H and IntOMICS algorithm were found in other databases, respectively.</p>
    <p id="Par71"><italic>CNVs specific for MSS colon cancer</italic> IntOMICS identified edges from CNV to associated GE in five out of six genes of interest: KRAS, MYC, BIRC5, RAC3, and SMAD4. Even if the interaction from CCND1 CNV to CCND1 GE is not present in the resulting network structure, the edge weight is higher than the median of all edge weights in the resulting network.</p>
    <p id="Par72">Except five genes mentioned above, we should highlight other interesting interactions identified by IntOMICS: deletion of tumour suppressor SMAD2 directly connected with SMAD2 GE, amplification of proto-oncogene BRAF directly connected with BRAF GE, two DNA methylation probes located at the CpG island shore (2-kb-long region from CpG island) directly connected with FOS GE, and one DNA methylation probe directly connected with TGFBR2 GE. IntOMICS also identified interesting interplay between PIK3R5 CNV, one methylation probe located at CpG island of PIK3R5 and PIK3R5 GE. PIK3R5 was previously found to be mutated in colon cancer [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>].</p>
    <p id="Par73">The resulting regulatory network inferred by the IntOMICS algorithm using TCGA-COAD MSS stage II/III samples can be seen in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S7.</p>
    <p id="Par74"><italic>DNA methylation specific for MSI colon cancer</italic> IntOMICS identified six DNA methylation probes (all located at CpG island) as MLH1 direct regulators. There are no descendant nodes of the MLH1 gene. This is in concordance with the hypothesis that DNA methylation of the MLH1 promoter region influences its gene expression.</p>
    <p id="Par75">The resulting regulatory network inferred by the IntOMICS algorithm using TCGA-COAD MSI samples can be seen in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S8.</p>
    <p id="Par76"><italic>In Silico Dataset</italic> IntOMICS and W &amp;H performance using DREAM4 in silico gene expression dataset in terms of ROC is shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. The difference of IntOMICS AUC = 0.74, 83% CI = (0.71–0.78) and W &amp;H AUC = 0.75, 83% CI = (0.71–0.79) is not statistically significant. We can see slightly different sensitivity in the region of high specificity. However, the sensitivity is balanced if specificity decreases to 90%. Cohen’s <inline-formula id="IEq113"><alternatives><tex-math id="M241">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\kappa$$\end{document}</tex-math><mml:math id="M242"><mml:mi>κ</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq113.gif"/></alternatives></inline-formula> ranges between 0.22 to 0.59 (see Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1).<fig id="Fig3"><label>Fig. 3</label><caption><p>Performance comparison of IntOMICS and W &amp;H algorithm [<xref ref-type="bibr" rid="CR4">4</xref>] using in silico <bold>gene expression dataset.</bold> Receiver-operating characteristic curve (as a function of the edge weights) with 95% confidence interval serves as the main performance index</p></caption><graphic xlink:href="12859_2022_4891_Fig3_HTML" id="MO12"/></fig></p>
    <p id="Par77">Presented results indicate a difference in favour of IntOMICS, and we can conclude that the proposed framework can compete with the W &amp;H algorithm using only gene expression data.</p>
    <p id="Par78"><italic>Comparison with Algorithms for Multi</italic>-<italic>Omics</italic><italic>Regulatory Network Inference</italic> Both RACER and KiMONo tested (i) 50 interactions between CNV/METH and corresponding GE, and (ii) 11 interactions between TFs and their targets. On top of that, KiMONo allows CNV/METH to be a gene expression regulator of any other gene. RACER identified 17/50 interactions between CNV/METH and corresponding GE as significant. KiMONo identified 1/50 interactions between CNV/METH and corresponding GE as significant. On top of that, KiMONo identified another three interactions between CNV/METH and GE that were not tested by RACER or IntOMICS. Venn diagram of interactions between features originating from distinct <italic>omics</italic> modalities identified by RACER, KiMONo, and IntOMICS is shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>. RACER identified 3/11 interactions between TFs and their targets as significant (one of them was identified also by IntOMICS). KiMONo identified 1/11 interactions between TFs and their targets as significant (IntOMICS identified this interaction in the opposite direction).</p>
    <p id="Par79">KiMONo is also designed to test GE-GE interactions defined in the prior knowledge. We used 24 known GE-GE interactions from the KEGG Notch signalling pathway as the prior knowledge. KiMONo identified 1/24 GE-GE interactions from the prior knowledge as significant (from NOTCH3 GE to NCSTN GE). IntOMICS identified also 1/24 GE-GE interactions from the prior knowledge (from MAML2 GE to RBPJL GE).</p>
    <p id="Par80">These results suggest there is some overlap between these algorithms, especially between RACER and IntOMICS. However, all these methods have its disadvantages over the others. RACER does not test any GE-GE interactions except TFs and their targets. KiMONo does not test any GE-GE interactions except the prior knowledge. KiMONo also derived several CNV/METH-GE interactions that are not straightforward to interpret, such as interaction from NOTCH3 CNV to APH1B GE. IntOMICS requires considerable time complexity and is limited by the number of input features. Nevertheless, IntOMICS provides the best choice for detailed knowledge discovery from multi-<italic>omics</italic> data.<fig id="Fig4"><label>Fig. 4</label><caption><p>The intersection of interactions between features originating from distinct omics modalities identified by RACER, KiMONo, and IntOMICS</p></caption><graphic xlink:href="12859_2022_4891_Fig4_HTML" id="MO13"/></fig></p>
    <sec id="Sec12">
      <title>Real application of InfOMICS: ABCG2-related chemoresistance in MSS stage III colon cancer</title>
      <p id="Par81">There are several interesting differences in ABCG2 regulation in the PETACC-3 MSS samples. Genes with ABCG2 direct interaction determined by IntOMICS are listed in Table <xref rid="Tab4" ref-type="table">4</xref>. In all PETACC-3 MSS samples, IntOMICS identified direct interaction from ABCG2 CNV to ABCG2 GE.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Genes with ABCG2 direct interaction and the confidence of the regulation (<italic>w</italic>) determined by IntOMICS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="2">5FU/FA</th><th align="left" colspan="2">FOLFIRI</th></tr><tr><th align="left">Low-RFS</th><th align="left">High-RFS</th><th align="left">Low-RFS</th><th align="left">High-RFS</th></tr></thead><tbody><tr><td align="left">ELK1</td><td align="left">High</td><td align="left">Med</td><td align="left">Low</td><td align="left">Med</td></tr><tr><td align="left">HRAS</td><td align="left">Low</td><td align="left">Med</td><td align="left">Low</td><td align="left">High</td></tr><tr><td align="left">MAP3K1</td><td align="left">High</td><td align="left">Med</td><td align="left">Low</td><td align="left">NA</td></tr><tr><td align="left">MAP2K1</td><td align="left">Med</td><td align="left">High</td><td align="left">NA</td><td align="left">Low</td></tr><tr><td align="left">MAPK1/ERK2</td><td align="left">Low</td><td align="left">Low</td><td align="left">Med</td><td align="left">High</td></tr><tr><td align="left">MAPK3/ERK1</td><td align="left">High</td><td align="left">Low</td><td align="left">Low</td><td align="left">NA</td></tr><tr><td align="left">MRAS</td><td align="left">Low</td><td align="left">Low</td><td align="left">High</td><td align="left">Low</td></tr><tr><td align="left">MYC</td><td align="left">High</td><td align="left">Med</td><td align="left">Med</td><td align="left">Med</td></tr><tr><td align="left">MYCN</td><td align="left">Low</td><td align="left">Low</td><td align="left">Low</td><td align="left">High</td></tr><tr><td align="left">RAF1</td><td align="left">Med</td><td align="left">NA</td><td align="left">Low</td><td align="left">High</td></tr><tr><td align="left">RPS6KA3</td><td align="left">High</td><td align="left">NA</td><td align="left">NA</td><td align="left">Low</td></tr><tr><td align="left">ABCG2 CNV</td><td align="left">High</td><td align="left">High</td><td align="left">High</td><td align="left">High</td></tr></tbody></table><table-wrap-foot><p>Genes with the highest predictive potential are highlighted in bold. low <inline-formula id="IEq117"><alternatives><tex-math id="M243">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$w &lt; 0.5$$\end{document}</tex-math><mml:math id="M244"><mml:mrow><mml:mi>w</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq117.gif"/></alternatives></inline-formula> quantile of all edge weights; med <inline-formula id="IEq118"><alternatives><tex-math id="M245">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$0.5 \ge w &lt; 0.75$$\end{document}</tex-math><mml:math id="M246"><mml:mrow><mml:mn>0.5</mml:mn><mml:mo>≥</mml:mo><mml:mi>w</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.75</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq118.gif"/></alternatives></inline-formula> quantile of all edge weights; high empirical frequency <inline-formula id="IEq119"><alternatives><tex-math id="M247">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$w \ge 0.75$$\end{document}</tex-math><mml:math id="M248"><mml:mrow><mml:mi>w</mml:mi><mml:mo>≥</mml:mo><mml:mn>0.75</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq119.gif"/></alternatives></inline-formula> quantile of all edge weights; NA the edge was not identified</p></table-wrap-foot></table-wrap></p>
      <p id="Par82">MAPK3/ERK1 and RPS6KA3 genes are identified as the direct regulators of the ABCG2 gene in the 5FU/FA low-RFS samples. In contrast, the confidence of ABCG2 regulation by these genes is very low in other groups. These results support the findings of [<xref ref-type="bibr" rid="CR70">70</xref>] about the regulation of ABCG2 by MAPK3/ERK1, which can have therapeutic consequences.</p>
      <p id="Par83">MRAS is identified as the direct regulator of the ABCG2 gene only in the FOLFIRI low-RFS samples (the confidence of MRAS GE and ABCG2 GE direct regulation is very low in other groups).</p>
      <p id="Par84">MYCN is identified as the direct regulator of the ABCG2 gene in the FOLFIRI high-RFS samples (the confidence of MYCN GE and ABCG2 GE direct regulation is very low in other groups). ABCG2 contributes to chemoresistance through the efflux of anticancer drugs from cancer cells [<xref ref-type="bibr" rid="CR73">73</xref>] and MYCN was shown to be positive regulator of ABCG2 [<xref ref-type="bibr" rid="CR69">69</xref>]. We can hypothesise that the direct interaction between MYCN GE and ABCG2 GE in the group of FOLFIRI high-RFS samples does not necessarily lead to irinotecan resistance development. We do not observe statistically significant difference in MYCN GE or ABCG2 GE between groups (Kruskal-Wallis test; <italic>p</italic>-value <inline-formula id="IEq114"><alternatives><tex-math id="M249">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\ge$$\end{document}</tex-math><mml:math id="M250"><mml:mo>≥</mml:mo></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq114.gif"/></alternatives></inline-formula> 0.1). On the contrary, the Spearman’s corelation coefficient test between ABCG2 GE and MYCN GE is at the margin of statistical significance in the FOLFIRI high-RFS samples and the correlation coefficient is positive in comparison with other groups (see Table <xref rid="Tab5" ref-type="table">5</xref>). The role of MYCN in ABCG2-related chemoresistance remains uncertain.<table-wrap id="Tab5"><label>Table 5</label><caption><p>Spearman’s correlation coefficient between ABCG2 GE and MYCN GE in MSS stage III colon cancer and corresponding <italic>p</italic>-value</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Treatment and survival</th><th align="left"><inline-formula id="IEq115"><alternatives><tex-math id="M251">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\rho$$\end{document}</tex-math><mml:math id="M252"><mml:mi>ρ</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq115.gif"/></alternatives></inline-formula></th><th align="left"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left">5FU/FA low-RFS</td><td char="." align="char">− 0.17</td><td char="." align="char">0.35</td></tr><tr><td align="left">5FU/FA high-RFS</td><td char="." align="char">− 0.11</td><td char="." align="char">0.41</td></tr><tr><td align="left">FOLFIRI low-RFS</td><td char="." align="char">− 0.01</td><td char="." align="char">0.96</td></tr><tr><td align="left">FOLFIRI high-RFS</td><td char="." align="char">0.23</td><td char="." align="char">0.09</td></tr></tbody></table><table-wrap-foot><p><inline-formula id="IEq116"><alternatives><tex-math id="M253">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\rho$$\end{document}</tex-math><mml:math id="M254"><mml:mi>ρ</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq116.gif"/></alternatives></inline-formula> Spearman’s correlation coefficient; <italic>5FU/FA</italic> fluorouracil/leucovorin, <italic>FOLFIRI</italic> fluorouracil/leucovorin with irinotecan, <italic>RFS</italic> relapse-free survival</p></table-wrap-foot></table-wrap></p>
      <p id="Par85">In our study, MAPK3/ERK1, MRAS, MYCN, and RPS6KA3 have the highest predictive potential.</p>
      <p id="Par86">The direct interaction from MAPK1/ERK2 to ABCG2 is detected in FOLFIRI high-RFS samples. In the context of ABCG2 regulation, we can speculate about the functional redundancy of MAPK1/ERK2 and MAPK3/ERK1.</p>
    </sec>
  </sec>
  <sec id="Sec13">
    <title>Discussion</title>
    <p id="Par87">We present IntOMICS, a Bayesian framework for multi-<italic>omics</italic> data and prior knowledge integration to infer regulatory networks using a novel approach to biological knowledge discovery. Besides the integration of known interactions as prior knowledge, IntOMICS complements the prior knowledge using <italic>empirical</italic> biological matrix, which reflects hidden patterns in the available datasets. IntOMICS is designed to infer not only dependencies among gene expression but also between gene expression, DNA methylation and copy number variation. Pathogenic copy number variations and epigenetic changes (such as DNA methylation) can affect gene expression, contribute to increased DNA instability and play an essential role in the initiation and progression of complex diseases such as cancer. The great benefit of IntOMICS is the use of continuous data. Because frequently used data discretisation in multi-<italic>omics</italic> data analysis implies substantial information loss. The proposed framework minimises the weaknesses of MCMC-based algorithms utilising state-of-the-art approaches such as Markov blanket resampling or adaptive MCMC algorithm. IntOMICS can be extended with any additional modality if the proposed model assumptions are satisfied (variables come from the multivariate Gaussian distribution).</p>
    <p id="Par88">Although IntOMICS evaluation and application is demonstrated using <italic>multi</italic>-omics data of colon cancer samples, it is not limited to any particular phenotype.</p>
    <p id="Par89">We have to mention that IntOMICS is not designed to infer genome-wide regulatory networks because of time complexity. At present, IntOMICS is restricted to infer regulatory networks within pathways with up to tens of features (nodes).</p>
    <p id="Par90">The main limitations of IntOMICS are time complexity and limited flexibility of the linear model. Therefore, the maximal number of parents for a node is limited. The BGe score does not provide such modelling flexibility and enables the modelling of only linear relationships between features. However, relationships in biological systems are more variable and complex. For example, co-regulation of a given gene by two exclusive regulators cannot be captured with a linear model. Moreover, Bayesian networks are also restricted to acyclicity and no feedback loops, common biological features. The user must always consider these limitations during the interpretation of the IntOMICS results.</p>
    <p id="Par91">Our Bayesian network-based framework tuned for gene expression, copy number variation, and DNA methylation is designed to work on any modalities defined in a continuous domain. However, IntOMICS is designed to infer regulatory network, even if copy number variation or DNA methylation data (or both) are not available.</p>
    <p id="Par92">Regarding future work, our Bayesian network-based framework could be extended by additional omics data types, such as miRNAs. Our next objective is to upgrade the proposed workflow to infer regulatory networks with an extensive set of features.</p>
    <p id="Par93">At the gene expression level, the performance of IntOMICS is comparable with a published algorithm based on Bayesian networks using both real and in silico datasets. In the context of multi-<italic>omics</italic> data, IntOMICS performance is significantly better in comparison with a published algorithm based on Bayesian networks. The ability to capture relevant crosstalks between copy number variation and gene expression is verified using known associations between copy number variation and gene expression in microsatellite stable stage II/III colon cancer samples. IntOMICS identified five out of six known associations. Microsatellite instable samples were used to verify crosstalks between gene expression and methylation. IntOMICS identified six DNA methylation probes as MLH1 direct regulators together with associated CNV.</p>
    <p id="Par94">Additionally, IntOMICS performance was compared with two algorithms for multi-<italic>omics</italic> regulatory network inference that can also incorporate prior knowledge in the inference framework. There is overlap of interactions between features originating from distinct <italic>omics</italic> modalities. However, all these algorithms have their advantages over the others. IntOMICS should be used if we are interested in detailed knowledge discovery from multi-<italic>omics</italic> data. Besides inferring relevant crosstalks between multi-<italic>omics</italic> modalities, IntOMICS is designed to capture also interactions within gene expression.</p>
    <p id="Par95">Using our novel framework, several ABCG2 regulator genes are discovered as potential predictive markers in microsatellite stable stage III colon cancer samples. However, all regulatory relationships discovered by IntOMICS need to be verified using more refined approaches.</p>
    <p id="Par96">IntOMICS is a powerful resource for exploratory systems biology and can provide valuable insights into the complex mechanisms of biological processes that has a vital role in personalised medicine.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec14">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12859_2022_4891_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1: Fig. S1.</bold> Different IntOMICS hyperparameters setting in DREAM4 in silico dataset and the resulting ROC with 95% confidence intervals. <bold>Fig. S2.</bold> Different IntOMICS hyperparameters setting in DREAM4 in silico dataset and the resulting AUC with 83% confidence intervals. <bold>Fig. S3.</bold> Trace plot of β values using the W&amp;H algorithm. <bold>Fig. S4.</bold> Consistency in the marginal posterior probabilities of the edges using the W&amp;H algorithm. <bold>Fig. S5.</bold> Trace plot of β values using the IntOMICS algorithm. <bold>Fig. S6.</bold> Consistency in the marginal posterior probabilities of the edges using the IntOMICS algorithm. <bold>Fig. S7.</bold> CNVs specific for MSS colon cancer investigation and the resulting regulatory network inferred by IntOMICS algorithm using TCGA-COAD MSS stageII/III samples. <bold>Fig. S8.</bold> DNA methylation specific for MSI colon cancer investigation and the resulting regulatory network inferred by IntOMICS algorithm using TCGA-COAD MSI samples.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="12859_2022_4891_MOESM2_ESM.pdf">
            <caption>
              <p><bold>Additional file 2. Table S1.</bold> The performance of IntOMICS and W&amp;H algorithm: corresponding AUC with 83% CIs, Cohen's Kappa coefficient, and running time.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Authors thank to Research Infrastructure RECETOX RI [LM2018121] financed by the Ministry of Education, Youth and Sports, and Operational Programme Research, Development and Innovation—project CETOCOEN EXCELLENCE [CZ.02.1.01/0.0/0.0/17_043/0009632] for supportive background. Access to computing and storage facilities owned by parties and projects contributing to the National Grid Infrastructure MetaCentrum provided under the programme “Projects of Large Research, Development, and Innovations Infrastructures” CESNET [LM2015042] is greatly appreciated. The published results here are partly based upon data generated by the TCGA Research Network:<ext-link ext-link-type="uri" xlink:href="https://www.cancer.gov/tcga.">https://www.cancer.gov/tcga.</ext-link></p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>AP and VP designed the research. The code was developed and written by AP. The evaluation was performed by AP and VP. Both authors have read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825410. </p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>Source code and data used for producing the presented results are available at: <ext-link ext-link-type="uri" xlink:href="https://gitlab.ics.muni.cz/bias/intomics">https://gitlab.ics.muni.cz/bias/intomics.</ext-link> KEGG pathways used in the current study are publicly available and were downloaded from the KEGG pathway database (<ext-link ext-link-type="uri" xlink:href="https://www.genome.jp/kegg/pathway.html">https://www.genome.jp/kegg/pathway.html</ext-link>). Known interactions between transcription factors and their targets were downloaded from the Harmonizome (collection of processed datasets; <ext-link ext-link-type="uri" xlink:href="https://maayanlab.cloud/Harmonizome/dataset/ENCODE+Transcription+Factor+Targets)">https://maayanlab.cloud/Harmonizome/dataset/ENCODE+Transcription+Factor+Targets)</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar2">
      <title>Ethics approval and consent to participate</title>
      <p id="Par97">Not applicable.</p>
    </notes>
    <notes id="FPar3">
      <title>Consent for publication</title>
      <p id="Par98">Not applicable.</p>
    </notes>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par99">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Djebbari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Quackenbush</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Seeded Bayesian Networks: constructing genetic networks from microarray data</article-title>
        <source>BMC Syst Biol.</source>
        <year>2008</year>
        <pub-id pub-id-type="doi">10.1186/1752-0509-2-57</pub-id>
        <?supplied-pmid 18601736?>
        <pub-id pub-id-type="pmid">18601736</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Quantitative utilization of prior biological knowledge in the Bayesian network modeling of gene expression data</article-title>
        <source>BMC Bioinform.</source>
        <year>2011</year>
        <pub-id pub-id-type="doi">10.1186/1471-2105-12-359</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Imoto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Higuchi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tashiro</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kuhara</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Miyano</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Combining microarrays and biological knowledge for estimating gene networks via Bayesian networks</article-title>
        <source>J. Bioinform. Comput. Biol.</source>
        <year>2004</year>
        <volume>2</volume>
        <fpage>77</fpage>
        <lpage>98</lpage>
        <pub-id pub-id-type="doi">10.1142/s021972000400048x</pub-id>
        <?supplied-pmid 15272434?>
        <pub-id pub-id-type="pmid">15272434</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Werhli</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Husmeier</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Reconstructing gene regulatory networks with bayesian networks by combining expression data with multiple sources of prior knowledge</article-title>
        <source>Stat Appl Genet Mol Biol.</source>
        <year>2007</year>
        <pub-id pub-id-type="doi">10.2202/1544-6115.1282</pub-id>
        <?supplied-pmid 17542777?>
        <pub-id pub-id-type="pmid">17542777</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <mixed-citation publication-type="other">de Campos LM, Cano A, Castellano JG, Moral S. Combining gene expression data and prior knowledge for inferring gene regulatory networks via Bayesian networks using structural restrictions. Stat Appl Genet Mol Biol. 2019;18.</mixed-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Calkhoven</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Ab</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Multiple steps in the regulation of transcription-factor level and activity</article-title>
        <source>Biochem J.</source>
        <year>1996</year>
        <volume>317</volume>
        <fpage>329</fpage>
        <lpage>342</lpage>
        <pub-id pub-id-type="doi">10.1042/bj3170329</pub-id>
        <?supplied-pmid 8713055?>
        <pub-id pub-id-type="pmid">8713055</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shlien</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Malkin</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Copy number variations and cancer</article-title>
        <source>Genome Med.</source>
        <year>2009</year>
        <pub-id pub-id-type="doi">10.1186/gm62</pub-id>
        <?supplied-pmid 19566914?>
        <pub-id pub-id-type="pmid">19566914</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Herman</surname>
            <given-names>JG</given-names>
          </name>
        </person-group>
        <article-title>Hypermethylation of tumor suppressor genes in cancer</article-title>
        <source>Semin Cancer Biol.</source>
        <year>1999</year>
        <volume>9</volume>
        <fpage>359</fpage>
        <lpage>367</lpage>
        <pub-id pub-id-type="doi">10.1006/scbi.1999.0138</pub-id>
        <?supplied-pmid 10547344?>
        <pub-id pub-id-type="pmid">10547344</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lister</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pelizzola</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dowen</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Hawkins</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Hon</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tonti-Filippini</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nery</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ngo</surname>
            <given-names>Q-M</given-names>
          </name>
          <name>
            <surname>Edsall</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Antosiewicz-Bourget</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stewart</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ruotti</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Millar</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Thomson</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ecker</surname>
            <given-names>JR</given-names>
          </name>
        </person-group>
        <article-title>Human DNA methylomes at base resolution show widespread epigenomic differences</article-title>
        <source>Nature</source>
        <year>2009</year>
        <volume>462</volume>
        <fpage>315</fpage>
        <lpage>322</lpage>
        <pub-id pub-id-type="doi">10.1038/nature08514</pub-id>
        <?supplied-pmid 19829295?>
        <pub-id pub-id-type="pmid">19829295</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brenet</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Moh</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Funk</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Feierstein</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Viale</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Socci</surname>
            <given-names>ND</given-names>
          </name>
          <name>
            <surname>Scandura</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>DNA methylation of the first exon is tightly linked to transcriptional silencing</article-title>
        <source>PLoS ONE.</source>
        <year>2011</year>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0014524</pub-id>
        <?supplied-pmid 21267076?>
        <pub-id pub-id-type="pmid">21267076</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>de Carvalho</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Lay</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Gene body methylation can alter gene expression and is a therapeutic target in cancer</article-title>
        <source>Cancer Cell</source>
        <year>2014</year>
        <volume>26</volume>
        <fpage>577</fpage>
        <lpage>590</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ccr.2014.07.028</pub-id>
        <?supplied-pmid 25263941?>
        <pub-id pub-id-type="pmid">25263941</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mitra</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Müller</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ji</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>A Bayesian graphical model for integrative analysis of TCGA data</article-title>
        <source>IEEE Int Workshop Genomic Signal Process Stat.</source>
        <year>2012</year>
        <pub-id pub-id-type="doi">10.1109/GENSIPS.2012.6507747</pub-id>
        <?supplied-pmid 26726304?>
        <pub-id pub-id-type="pmid">26726304</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ni</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Stingo</surname>
            <given-names>FC</given-names>
          </name>
          <name>
            <surname>Baladandayuthapani</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Integrative Bayesian network analysis of genomic data</article-title>
        <source>Cancer Inform.</source>
        <year>2014</year>
        <volume>13</volume>
        <fpage>39</fpage>
        <lpage>48</lpage>
        <pub-id pub-id-type="doi">10.4137/CIN.S13786</pub-id>
        <?supplied-pmid 25288878?>
        <pub-id pub-id-type="pmid">25288878</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">Kim D-C, Kang M, Zhang B, Wu X, Liu C, Gao J. Integration of DNA methylation, copy number variation, and gene expression for gene regulatory network inference and application to psychiatric disorders. In: 2014 IEEE international conference on bioinformatics and bioengineering, 2014;238–42. 10.1109/BIBE.2014.71.</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zarayeneh</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ko</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Suh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Integration of multi-omics data for integrative gene regulatory network inference</article-title>
        <source>Int J Data Min Bioinform</source>
        <year>2017</year>
        <volume>18</volume>
        <fpage>223</fpage>
        <lpage>239</lpage>
        <pub-id pub-id-type="doi">10.1504/IJDMB.2017.10008266</pub-id>
        <?supplied-pmid 29354189?>
        <pub-id pub-id-type="pmid">29354189</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yuan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>L-H</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>C-A</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y-H</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nandi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Honig</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>D-S</given-names>
          </name>
        </person-group>
        <article-title>Integration of Multi-omics Data for Gene Regulatory Network Inference and Application to Breast Cancer</article-title>
        <source>EEE/ACM Trans Comput Biol Bioinform</source>
        <year>2018</year>
        <volume>16</volume>
        <fpage>782</fpage>
        <lpage>791</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2018.2866836</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hoang</surname>
            <given-names>TH</given-names>
          </name>
          <name>
            <surname>Joshi</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>S-H</given-names>
          </name>
          <name>
            <surname>Giardina</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Shin</surname>
            <given-names>D-G</given-names>
          </name>
        </person-group>
        <article-title>A route-based pathway analysis framework integrating mutation information and gene expression data</article-title>
        <source>Methods</source>
        <year>2017</year>
        <volume>124</volume>
        <fpage>3</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ymeth.2017.06.016</pub-id>
        <?supplied-pmid 28647608?>
        <pub-id pub-id-type="pmid">28647608</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Regression analysis of combined gene expression regulation in acute Myeloid Leukemia</article-title>
        <source>PLOS Comput Biol.</source>
        <year>2014</year>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003908</pub-id>
        <?supplied-pmid 25521832?>
        <pub-id pub-id-type="pmid">25521832</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dugourd</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kuppe</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sciacovelli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gjerga</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gabor</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Emdal</surname>
            <given-names>KB</given-names>
          </name>
          <name>
            <surname>Vieira</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Bekker-Jensen</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Kranz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bindels</surname>
            <given-names>EMJ</given-names>
          </name>
          <name>
            <surname>Costa</surname>
            <given-names>ASH</given-names>
          </name>
          <name>
            <surname>Sousa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Beltrao</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rocha</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Olsen</surname>
            <given-names>JV</given-names>
          </name>
          <name>
            <surname>Frezza</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kramann</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Saez-Rodriguez</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Causal integration of multi-omics data with prior knowledge to generate mechanistic hypotheses</article-title>
        <source>Mol Syst Biol.</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.15252/msb.20209730</pub-id>
        <?supplied-pmid 34939300?>
        <pub-id pub-id-type="pmid">34939300</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Trairatphisan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gjerga</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Didangelos</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Barratt</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Saez-Rodriguez</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>From expression footprints to causal pathways: contextualizing large signaling networks with CARNIVAL</article-title>
        <source>npj Syst Biol Appl</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1038/s41540-019-0118-z</pub-id>
        <?supplied-pmid 31728204?>
        <pub-id pub-id-type="pmid">31728204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ogris</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Arloth</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Müller</surname>
            <given-names>NS</given-names>
          </name>
        </person-group>
        <article-title>Versatile knowledge guided network inference method for prioritizing key regulatory factors in multi-omics data</article-title>
        <source>Sci Rep.</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1038/s41598-021-85544-4</pub-id>
        <?supplied-pmid 34645873?>
        <pub-id pub-id-type="pmid">34645873</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Simon</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Friedman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hastie</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tibshirani</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>A Sparse-Group Lasso</article-title>
        <source>J Comput Graph Stat</source>
        <year>2013</year>
        <volume>22</volume>
        <fpage>231</fpage>
        <lpage>245</lpage>
        <pub-id pub-id-type="doi">10.1080/10618600.2012.681250</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Siebert</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Saint-Cyr</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Borengasser</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>Lozupone</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Görg</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>CANTARE: finding and visualizing network-based multi-omic predictive models</article-title>
        <source>BMC Bioinform.</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1186/s12859-021-04016-8</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lappalainen</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lopez</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Skipper</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hefferon</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Spalding</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Garner</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Maguire</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Corbett</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Paschall</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ananiev</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Flicek</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>DM</given-names>
          </name>
        </person-group>
        <article-title>DbVar and DGVa: public archives for genomic structural variation</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>936</fpage>
        <lpage>941</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1213</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Komaki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Shiwa</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Furukawa</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hachiya</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ohmomo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Otomo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Satoh</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hitomi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sobue</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sasaki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shimizu</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>iMETHYL: an integrative database of human DNA methylation, gene expression, and genomic variation</article-title>
        <source>Human Genome Var.</source>
        <year>2018</year>
        <pub-id pub-id-type="doi">10.1038/hgv.2018.8</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Su</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Borsuk</surname>
            <given-names>ME</given-names>
          </name>
        </person-group>
        <article-title>Improving Structure MCMC for Bayesian Networks through Markov Blanket Resampling</article-title>
        <source>J Mach Learn Res</source>
        <year>2016</year>
        <volume>17</volume>
        <fpage>1</fpage>
        <lpage>20</lpage>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cooper</surname>
            <given-names>GF</given-names>
          </name>
          <name>
            <surname>Herskovits</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>A Bayesian method for the induction of probabilistic networks from data</article-title>
        <source>Mach Learn</source>
        <year>1992</year>
        <volume>9</volume>
        <fpage>309</fpage>
        <lpage>347</lpage>
        <pub-id pub-id-type="doi">10.1007/BF00994110</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <mixed-citation publication-type="other">Geiger D, Heckerman D. Learning Gaussian networks. In: Proceedings of the 10th conference on uncertainty in artificial intelligence, 1994;235–43.</mixed-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <mixed-citation publication-type="other">Grzegorczyk M. Comparative evaluation of different graphical models for the analysis of gene expression data. PhD thesis, The Department of Statistics of the University Dortmund. 2006. 10.17877/DE290R-607.</mixed-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rosenthal</surname>
            <given-names>JS</given-names>
          </name>
        </person-group>
        <article-title>Automatically tuned general-purpose MCMC via new adaptive diagnostics</article-title>
        <source>Comput Stat</source>
        <year>2017</year>
        <volume>32</volume>
        <fpage>315</fpage>
        <lpage>348</lpage>
        <pub-id pub-id-type="doi">10.1007/s00180-016-0682-2</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ogata</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fujibuchi</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Bono</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kanehisa</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>KEGG: Kyoto Encyclopedia of Genes and Genomes</article-title>
        <source>Nucleic Acids Res</source>
        <year>1999</year>
        <volume>27</volume>
        <fpage>29</fpage>
        <lpage>34</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/27.1.29</pub-id>
        <?supplied-pmid 9847135?>
        <pub-id pub-id-type="pmid">9847135</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <mixed-citation publication-type="other">Consortium, E.P. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science. 2004;306:636–40. 10.1126/science.1105136.</mixed-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <mixed-citation publication-type="other">E.P., Consortium. A user’s guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 2011;9. 10.1371/journal.pbio.1001046.</mixed-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rouillard</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Gundersen</surname>
            <given-names>GW</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>NF</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Monteiro</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>McDermott</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins</article-title>
        <source>Database</source>
        <year>2016</year>
        <pub-id pub-id-type="doi">10.1093/database/baw100</pub-id>
        <?supplied-pmid 27374120?>
        <pub-id pub-id-type="pmid">27374120</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Madigan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>York</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Allard</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Bayesian graphical models for discrete data</article-title>
        <source>Int Stat Rev/Revue Internationale De Statistique</source>
        <year>1995</year>
        <volume>63</volume>
        <fpage>215</fpage>
        <lpage>232</lpage>
        <pub-id pub-id-type="doi">10.2307/1403615</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hastings</surname>
            <given-names>WK</given-names>
          </name>
        </person-group>
        <article-title>Monte Carlo sampling methods using Markov chains and their applications</article-title>
        <source>Biometrika</source>
        <year>1970</year>
        <volume>51</volume>
        <fpage>97</fpage>
        <lpage>109</lpage>
        <pub-id pub-id-type="doi">10.2307/2334940</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peterson</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Cavanaugh</surname>
            <given-names>JE</given-names>
          </name>
        </person-group>
        <article-title>Ordered quantile normalization: a semiparametric transformation built for the cross-validation era</article-title>
        <source>J Appl Stat</source>
        <year>2020</year>
        <volume>47</volume>
        <fpage>2312</fpage>
        <lpage>2327</lpage>
        <pub-id pub-id-type="doi">10.1080/02664763.2019.1630372</pub-id>
        <?supplied-pmid 35707424?>
        <pub-id pub-id-type="pmid">35707424</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Agostinho</surname>
            <given-names>NB</given-names>
          </name>
          <name>
            <surname>Machado</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Werhli</surname>
            <given-names>AV</given-names>
          </name>
        </person-group>
        <article-title>Inference of regulatory networks with a convergence improved MCMC sampler</article-title>
        <source>BMC Bioinform.</source>
        <year>2015</year>
        <pub-id pub-id-type="doi">10.1186/s12859-015-0734-6</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Leclerc</surname>
            <given-names>RD</given-names>
          </name>
        </person-group>
        <article-title>Survival of the sparsest: robust gene networks are parsimonious</article-title>
        <source>Mol Syst Biol.</source>
        <year>2008</year>
        <pub-id pub-id-type="doi">10.1038/msb.2008.52</pub-id>
        <?supplied-pmid 18682703?>
        <pub-id pub-id-type="pmid">18682703</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stolovitzky</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Monroe</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Califano</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Dialogue on reverse-engineering assessment and methods: the DREAM of high-throughput pathway inference</article-title>
        <source>Ann N Y Acad Sci</source>
        <year>2007</year>
        <volume>1115</volume>
        <fpage>1</fpage>
        <lpage>22</lpage>
        <pub-id pub-id-type="doi">10.1196/annals.1407.021</pub-id>
        <?supplied-pmid 17925349?>
        <pub-id pub-id-type="pmid">17925349</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Marbach</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Schaffter</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mattiussi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Floreano</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Generating realistic in silico gene networks for performance assessment of reverse engineering methods</article-title>
        <source>J Comput Biol.</source>
        <year>2009</year>
        <volume>16</volume>
        <fpage>229</fpage>
        <lpage>239</lpage>
        <pub-id pub-id-type="doi">10.1089/cmb.2008.09TT</pub-id>
        <?supplied-pmid 19183003?>
        <pub-id pub-id-type="pmid">19183003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prill</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Marbach</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Saez-Rodriguez</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sorger</surname>
            <given-names>PK</given-names>
          </name>
          <name>
            <surname>Alexopoulos</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Clarke</surname>
            <given-names>ND</given-names>
          </name>
          <name>
            <surname>Altan-Bonnet</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Stolovitzky</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Towards a rigorous assessment of systems biology models: the DREAM3 challenges</article-title>
        <source>PLoS ONE.</source>
        <year>2010</year>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0009202</pub-id>
        <?supplied-pmid 20186320?>
        <pub-id pub-id-type="pmid">20186320</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Marbach</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Costello</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Kffner</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Vega</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Prill</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Camacho</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Allison</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Kellis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Collins</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Stolovitzky</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Wisdom of crowds for robust gene network inference</article-title>
        <source>Nat Methods.</source>
        <year>2012</year>
        <volume>9</volume>
        <fpage>796</fpage>
        <lpage>804</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.2016</pub-id>
        <?supplied-pmid 22796662?>
        <pub-id pub-id-type="pmid">22796662</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Barker</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Clevers</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Mining the Wnt pathway for cancer therapeutics</article-title>
        <source>Nat Rev Drug Discov</source>
        <year>2006</year>
        <volume>5</volume>
        <fpage>997</fpage>
        <lpage>1014</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd2154</pub-id>
        <?supplied-pmid 17139285?>
        <pub-id pub-id-type="pmid">17139285</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sebio</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kahn</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lenz</surname>
            <given-names>H-J</given-names>
          </name>
        </person-group>
        <article-title>The potential of targeting Wnt/<inline-formula id="IEq124"><alternatives><tex-math id="M255">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M256"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq124.gif"/></alternatives></inline-formula>-catenin in colon cancer</article-title>
        <source>Expert Opin Ther Targets</source>
        <year>2014</year>
        <volume>18</volume>
        <fpage>611</fpage>
        <lpage>615</lpage>
        <pub-id pub-id-type="doi">10.1517/14728222.2014.906580</pub-id>
        <pub-id pub-id-type="pmid">24702624</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Novellasdemunt</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Antas</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>VSW</given-names>
          </name>
        </person-group>
        <article-title>Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms</article-title>
        <source>Am J Physiol Cell Physiol</source>
        <year>2015</year>
        <volume>309</volume>
        <fpage>511</fpage>
        <lpage>521</lpage>
        <pub-id pub-id-type="doi">10.1152/ajpcell.00117.2015</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Duchartre</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>Y-M</given-names>
          </name>
          <name>
            <surname>Kahn</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The Wnt signaling pathway in cancer</article-title>
        <source>Crit Rev Oncol Hematol</source>
        <year>2016</year>
        <volume>99</volume>
        <fpage>141</fpage>
        <lpage>149</lpage>
        <pub-id pub-id-type="doi">10.1016/j.critrevonc.2015.12.005</pub-id>
        <?supplied-pmid 26775730?>
        <pub-id pub-id-type="pmid">26775730</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moore</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>DNA methylation and its basic function</article-title>
        <source>Neuropsychopharmacol</source>
        <year>2013</year>
        <volume>38</volume>
        <fpage>23</fpage>
        <lpage>38</lpage>
        <pub-id pub-id-type="doi">10.1038/npp.2012.112</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Du</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>C-C</given-names>
          </name>
          <name>
            <surname>Jafari</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kibbe</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis</article-title>
        <source>BMC Bioinform.</source>
        <year>2010</year>
        <pub-id pub-id-type="doi">10.1186/1471-2105-11-587</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hadley</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Glessner</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>SFA</given-names>
          </name>
          <name>
            <surname>Hakonarson</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bucan</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data</article-title>
        <source>Genome Res</source>
        <year>2007</year>
        <volume>17</volume>
        <fpage>1665</fpage>
        <lpage>1674</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.6861907</pub-id>
        <?supplied-pmid 17921354?>
        <pub-id pub-id-type="pmid">17921354</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Weinstein</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Collisson</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Mills</surname>
            <given-names>GB</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>KRM</given-names>
          </name>
          <name>
            <surname>Ozenberger</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Ellrott</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shmulevich</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>The cancer genome atlas pan-cancer analysis project</article-title>
        <source>Nat Genet</source>
        <year>2013</year>
        <volume>45</volume>
        <fpage>1113</fpage>
        <lpage>1120</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2764</pub-id>
        <?supplied-pmid 24071849?>
        <pub-id pub-id-type="pmid">24071849</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pačínková</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Popovici</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Cross-platform data analysis reveals a generic gene expression signature for microsatellite instability in colorectal cancer</article-title>
        <source>Biomed Res Int</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1155/2019/6763596</pub-id>
        <?supplied-pmid 31008109?>
        <pub-id pub-id-type="pmid">31008109</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Van Cutsem</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Labianca</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bodoky</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Barone</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Aranda</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nordlinger</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Topham</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tabernero</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>André</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sobrero</surname>
            <given-names>AF</given-names>
          </name>
          <name>
            <surname>Mini</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Greil</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Costanzo</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Collette</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cisar</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Khayat</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bokemeyer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Cunningham</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3</article-title>
        <source>J Clin Oncol</source>
        <year>2009</year>
        <volume>27</volume>
        <fpage>3117</fpage>
        <lpage>3125</lpage>
        <pub-id pub-id-type="doi">10.1200/JCO.2008.21.6663</pub-id>
        <?supplied-pmid 19451425?>
        <pub-id pub-id-type="pmid">19451425</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xie</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>d’Ario</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Lamb</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tejpar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Delorenzi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bosman</surname>
            <given-names>FT</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bougel</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Narzo</surname>
            <given-names>AFD</given-names>
          </name>
          <name>
            <surname>Popovici</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Budinská</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Mao</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Weinrich</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Rejto</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Hodgson</surname>
            <given-names>JG</given-names>
          </name>
        </person-group>
        <article-title>A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations</article-title>
        <source>PLoS ONE.</source>
        <year>2012</year>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0042001</pub-id>
        <?supplied-pmid 23300932?>
        <pub-id pub-id-type="pmid">23300932</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goldstein</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Healy</surname>
            <given-names>MJR</given-names>
          </name>
        </person-group>
        <article-title>The graphical presentation of a collection of means</article-title>
        <source>J R Stat Soc</source>
        <year>1995</year>
        <volume>158</volume>
        <fpage>175</fpage>
        <lpage>177</lpage>
        <pub-id pub-id-type="doi">10.2307/2983411</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hermjakob</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Montecchi-Palazzi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Lewington</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mudali</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kerrien</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Orchard</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vingron</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Roechert</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Roepstorff</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Valencia</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Margalit</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Armstrong</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bairoch</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cesareni</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sherman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Apweiler</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>IntAct: an open source molecular interaction database</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2004</year>
        <volume>32</volume>
        <fpage>452</fpage>
        <lpage>455</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkh052</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stark</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Breitkreutz</surname>
            <given-names>B-J</given-names>
          </name>
          <name>
            <surname>Reguly</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Boucher</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Breitkreutz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tyers</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>BioGRID: a general repository for interaction datasets</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2006</year>
        <volume>34</volume>
        <fpage>535</fpage>
        <lpage>539</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkj109</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Haw</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Functional interaction network construction and analysis for disease discovery</article-title>
        <source>Methods Mol Biol.</source>
        <year>2017</year>
        <volume>1558</volume>
        <fpage>235</fpage>
        <lpage>253</lpage>
        <pub-id pub-id-type="doi">10.1007/978-1-4939-6783-4_11</pub-id>
        <?supplied-pmid 28150241?>
        <pub-id pub-id-type="pmid">28150241</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mirabelli-Primdahl</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Gryfe</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Millar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Luceri</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dale</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Holowaty</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bapat</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Gallinger</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Redston</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title><inline-formula id="IEq126"><alternatives><tex-math id="M257">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M258"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq126.gif"/></alternatives></inline-formula>-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway</article-title>
        <source>Cancer Res</source>
        <year>1999</year>
        <volume>59</volume>
        <fpage>3346</fpage>
        <lpage>3351</lpage>
        <?supplied-pmid 10416591?>
        <pub-id pub-id-type="pmid">10416591</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fukushima</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Itoh</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Horiuchi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Min</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Iku</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Imai</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability</article-title>
        <source>J Exp Clin Cancer Res</source>
        <year>2001</year>
        <volume>20</volume>
        <fpage>553</fpage>
        <lpage>559</lpage>
        <?supplied-pmid 11876551?>
        <pub-id pub-id-type="pmid">11876551</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jeong</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Mutation hotspots in the <inline-formula id="IEq128"><alternatives><tex-math id="M259">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M260"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq128.gif"/></alternatives></inline-formula>-catenin gene: lessons from the human cancer genome databases</article-title>
        <source>Mol Cells</source>
        <year>2019</year>
        <volume>42</volume>
        <fpage>8</fpage>
        <lpage>16</lpage>
        <pub-id pub-id-type="doi">10.14348/molcells.2018.0436</pub-id>
        <?supplied-pmid 30699286?>
        <pub-id pub-id-type="pmid">30699286</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bartom</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rendleman</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Ryan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Shilati</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Savas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chandel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Shilatifard</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title><inline-formula id="IEq130"><alternatives><tex-math id="M261">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M262"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="12859_2022_4891_Article_IEq130.gif"/></alternatives></inline-formula>-Catenin/Tcf7l2-dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer</article-title>
        <source>Sci Adv.</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1126/sciadv.aax0698</pub-id>
        <?supplied-pmid 32064314?>
        <pub-id pub-id-type="pmid">32064314</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Herman</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Umar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Polyak</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Graff</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Ahuja</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Issa</surname>
            <given-names>J-PJ</given-names>
          </name>
          <name>
            <surname>Markowitz</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Willson</surname>
            <given-names>JKV</given-names>
          </name>
          <name>
            <surname>Hamilton</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Kinzler</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Kane</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Kolodner</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Vogelstein</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Kunkel</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Baylin</surname>
            <given-names>SB</given-names>
          </name>
        </person-group>
        <article-title>Incidence and functional consequences of hmlh1 promoter hypermethylation in colorectal carcinoma</article-title>
        <source>Proc Natl Acad Sci USA</source>
        <year>1998</year>
        <volume>95</volume>
        <fpage>6870</fpage>
        <lpage>6875</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.95.12.6870</pub-id>
        <?supplied-pmid 9618505?>
        <pub-id pub-id-type="pmid">9618505</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuismanen</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Holmberg</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Salovaara</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>de la Chapelle</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Peltomäki</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Genetic and epigenetic modification of mlh1 accounts for a major share of microsatellite-unstable colorectal cancers</article-title>
        <source>Am J Pathol</source>
        <year>2000</year>
        <volume>156</volume>
        <fpage>1773</fpage>
        <lpage>1779</lpage>
        <pub-id pub-id-type="doi">10.1016/S0002-9440(10)65048-1</pub-id>
        <?supplied-pmid 10793088?>
        <pub-id pub-id-type="pmid">10793088</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tian</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Webster</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Beck</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Feber</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Teschendorff</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <article-title>ChAMP: updated methylation analysis pipeline for Illumina BeadChips</article-title>
        <source>Bioinformatics</source>
        <year>2017</year>
        <volume>33</volume>
        <fpage>3982</fpage>
        <lpage>3984</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx513</pub-id>
        <?supplied-pmid 28961746?>
        <pub-id pub-id-type="pmid">28961746</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bray</surname>
            <given-names>SJ</given-names>
          </name>
        </person-group>
        <article-title>Notch signalling: a simple pathway becomes complex</article-title>
        <source>Nat Rev Mol Cell Biol</source>
        <year>2006</year>
        <volume>7</volume>
        <fpage>678</fpage>
        <lpage>689</lpage>
        <pub-id pub-id-type="doi">10.1038/nrm2009</pub-id>
        <?supplied-pmid 16921404?>
        <pub-id pub-id-type="pmid">16921404</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stenvang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Budinská</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Van Cutsem</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bosman</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Brünner</surname>
            <given-names>VPN</given-names>
          </name>
        </person-group>
        <article-title>An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial</article-title>
        <source>Cancers</source>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.3390/cancers12040977</pub-id>
        <?supplied-pmid 32326511?>
        <pub-id pub-id-type="pmid">32326511</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Doyle</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Douglas</surname>
            <given-names>RD</given-names>
          </name>
        </person-group>
        <article-title>Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)</article-title>
        <source>Oncogene</source>
        <year>2003</year>
        <volume>22</volume>
        <fpage>7340</fpage>
        <lpage>7358</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.onc.1206938</pub-id>
        <?supplied-pmid 14576842?>
        <pub-id pub-id-type="pmid">14576842</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Porro</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Haber</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Diolaiti</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Iraci</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Henderson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gherardi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Valli</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Munoz</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Flemming</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schwab</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Valle</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Norris</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Perini</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells</article-title>
        <source>J Biol Chem</source>
        <year>2010</year>
        <volume>285</volume>
        <fpage>19532</fpage>
        <lpage>19543</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M109.078584</pub-id>
        <?supplied-pmid 20233711?>
        <pub-id pub-id-type="pmid">20233711</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>zu Schwabedissen</surname>
            <given-names>HEM</given-names>
          </name>
          <name>
            <surname>Grube</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dreisbach</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jedlitschky</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Meissner</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Linnemann</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fusch</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ritter</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Völker</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Kroemer</surname>
            <given-names>HK</given-names>
          </name>
        </person-group>
        <article-title>Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP)</article-title>
        <source>Drug Metab Dispos.</source>
        <year>2006</year>
        <volume>34</volume>
        <fpage>524</fpage>
        <lpage>33</lpage>
        <pub-id pub-id-type="doi">10.1124/dmd.105.007591</pub-id>
        <pub-id pub-id-type="pmid">16415123</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wood</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>Parsons</surname>
            <given-names>DW</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sjoblom</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Leary</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Boca</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Barber</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ptak</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Silliman</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Szabo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dezso</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ustyanksky</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Nikolskaya</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nikolsky</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Karchin</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kaminker</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Croshaw</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Willis</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dawson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Shipitsin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Willson</surname>
            <given-names>JKV</given-names>
          </name>
          <name>
            <surname>Sukumar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Polyak</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>BH</given-names>
          </name>
          <name>
            <surname>Pethiyagoda</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Pant</surname>
            <given-names>PVK</given-names>
          </name>
          <name>
            <surname>Ballinger</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Sparks</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Hartigan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Suh</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Papadopoulos</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Buckhaults</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Markowitz</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Parmigiani</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kinzler</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Velculescu</surname>
            <given-names>VE</given-names>
          </name>
          <name>
            <surname>Vogelstein</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>The genomic landscapes of human breast and colorectal cancers</article-title>
        <source>Science.</source>
        <year>2007</year>
        <volume>318</volume>
        <fpage>1108</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1145720</pub-id>
        <?supplied-pmid 17932254?>
        <pub-id pub-id-type="pmid">17932254</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Burghel</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>W-Y</given-names>
          </name>
          <name>
            <surname>Whitehouse</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Brock</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hammond</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bury</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stephenson</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>George</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Identification of candidate driver genes in common focal chromosomal aberrations of microsatellite stable colorectal cancer</article-title>
        <source>PLoS ONE.</source>
        <year>2013</year>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0083859</pub-id>
        <?supplied-pmid 24367615?>
        <pub-id pub-id-type="pmid">24367615</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fletcher</surname>
            <given-names>JI</given-names>
          </name>
          <name>
            <surname>Haber</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Henderson</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Norris</surname>
            <given-names>MD</given-names>
          </name>
        </person-group>
        <article-title>ABC transporters in cancer: more than just drug efflux pumps</article-title>
        <source>Nat Rev Cancer</source>
        <year>2010</year>
        <volume>10</volume>
        <fpage>147</fpage>
        <lpage>156</lpage>
        <pub-id pub-id-type="doi">10.1038/nrc2789</pub-id>
        <pub-id pub-id-type="pmid">20075923</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
